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General Introduction 
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Streptococcus suis (S. suis) is a Gram-positive coccus which commonly occurs as 
single cells, in pairs or in short chains (Wertheim et al., 2009). S. suis can be naturally found 
in the upper respiratory tract, especially in tonsils and nasal cavities, genital and alimentary 
tracts including salivary glands of healthy pigs (Arends et al., 1984; Gottschalk & Segura, 
2000; Padungtod et al., 2010). The rate of asymptomatic carrier in adult pigs may be nearly 
100% but the morbidity rarely exceeds 5% (Clifton-Hadley et al., 1986). Sow is a potential 
source of infection in the herd, and piglets can become infected from the sow harboring S. 
suis in uterus or vagina. However, the infection more likely occurs at weaning when they are 
moved, mixed and resided together (Staats et al., 1997). The carriers are also important for 
transmission of S. suis in herds via nasal and oral routes (Lun et al., 2007). The presumptive 
identification of S. suis is basically relied on the biochemical tests as following parameters: 
Voges-Proskauer negativity, hydrolysis of esculin positivity, trehalose positivity and 
negativity for growth in 6.5% NaCl (Tarradas et al., 1994). The molecular techniques using 
polymerase chain reaction (PCR) on the basis of S. suis-specific glutamate dehydrogenase 
gene (gdh) (Okwumabua et al., 2003), PCR on the basis of S. suis-specific 16s rRNA region 
and a species-specific probe targeting 16s rRNA gene (Chatellier et al., 1998; Lun et al., 
2007) are reliable tools for identification of S. suis.      
 According to the different antigenicity of the capsular polysaccharides, S. suis strains 
can be classified into 35 serotypes (serotypes 1-34 and serotype 1/2, which reacts with both 
anti-serotypes 1 and 2 sera) (Higgins & Gottschalk, 2006) but serotypes 32 and 34 were latter 
demonstrated to be Streptococcus orisratti (Hill et al., 2005). More recently, on the basis of 
the phylogenetic analyses of gene encoding the manganese-dependent superoxide dismutase 
(sodA) and a gene encoding recombination/repair protein (recN), serotypes 20, 22, 26 and 33 
were suggested to be taxonomically removed from S. suis (Tien le et al., 2013). The serotype 
identification method is generally based on the reaction between polysaccharide capsular 
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antigens and specific antiserum of each serotype using capsular reaction (Neufeld), capillary 
precipitation or co-agglutination test (Gottschalk et al., 1989; Perch et al., 1983). However, 
the serotyping on the basis of specific antiserum is laborious and costly. The multiplex PCR 
and PCR typing method using serotype-specific gene have been developed and at least 15 
serotypes (serotypes 1, 2, 3, 4, 5, 7, 8, 9, 10, 14, 16, 19, 23, 25 and 1/2) can be effectively 
identified to date (Kerdsin et al., 2009; Kerdsin et al., 2012; Okwumabua et al., 2003; Smith 
et al., 1999b; Smith et al., 1999c; Wang et al., 2011; Wang et al., 2012; Wisselink et al., 
2002). 
Among all serotypes so far described, serotype 2 was predominantly isolated from 
both infected pigs and patients (Higgins & Gottschalk, 2006; Wertheim et al., 2009). S. suis 
serotype 2 can tolerate in wide range environmental conditions. Although S. suis serotype 2 
can easily be inactivated by 5% bleach at 1:799 dilution, this microorganism can survive at 
60ﾟC for 10 min, at 50ﾟC for 2 h, and at 10ﾟC for 6 weeks in carcasses (Clifton-Hadley & 
Enright, 1984). At 0ﾟC, it can persist for 1 month in dust and 3 months in feces and at 25ﾟC, 
it can live for 24 h in dust and 8 days in feces (Clifton-Hadley & Enright, 1984). Due to its 
tolerance, S. suis serotype 2 can persist in various environments and often causes infection in 
many countries. 
 In pigs, S. suis infection has been reported in many countries of North America 
(United States and Canada), South America (Brazil), Europe (United Kingdom, Belgium, 
Denmark, Norway, Finland, Spain, Germany and Ireland), Asia (China, Hong Kong, 
Thailand, Vietnam and Japan), and Oceania (Australia and New Zealand) (Staats et al., 1997; 
Wertheim et al., 2009). Although the most frequent clinical manifestation of the infection in 
swine is meningitis, other clinical features, such as arthritis, endocarditis, pneumonia, 
abortion and vaginitis, commonly occur (Gottschalk et al., 2007). Without treatment, the 
mortality rate can reach 20% (Cloutier et al., 2003). S. suis has additionally been isolated 
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from other species such as dogs, cats, horses, ruminants and humans (Devriese et al., 1990; 
Devriese & Haesebrouck, 1992; Keymer et al., 1983; Muckle et al., 2010; Staats et al., 
1997). 
The isolates from diseased pigs in many countries were often limited to some 
serotypes (Gottschalk et al., 2007; Wisselink et al., 2000). Besides serotype 2, serotypes 9, 1, 
1/2 and 14 were also isolated from diseased pigs in European countries (Princivalli et al., 
2009; Wisselink et al., 2000). The notable numbers of strains belonging to serotypes 14, 9, 7, 
11, 8 and 1 were found in Brazil (Costa et al., 2005) and serotypes 3, 4, 8, 5, 7, 1/2 were 
isolated from infected pigs in China (Wei et al., 2009). However, the recent study (Gottschalk 
et al., 2013) reported that the prevalence of serotype 2 in Canada was almost the same as that 
of serotype 3 and the prevalence of serotype 2 in North America was still relatively low 
compared to European and Asian countries, suggesting that the difference of serotype 
distribution may result from the geographical location. Recently, followed by serotype 2, 
serotype 7 has been found to be the most predominant serotype circulating in slaughter pigs 
in China (Wang et al., 2013). Because the serotypes in human isolates correlate with those 
predominant in pigs in the same area, it is suggested that not only the potential cause of 
disease transmission in the herd, the healthy carrier pigs may also be the important source to 
spread S. suis to humans. Moreover, according to the analyses by multilocus sequence typing 
in a study by Onishi et al. (2012), S. suis isolates from pigs with endocarditis mostly belong 
to sequence type 1 and 28 complexes that are also the potential hazardous groups causing 
serious infection in humans. This result emphasized public health significance of S. suis 
lurking in porcine endocarditis. 
Since the first human case was reported in Denmark in 1968, the numbers of human 
case of S. suis infection have increased in many countries, particularly the area where the pig 
density is high (Wertheim et al., 2009). In the summer of 2005, the largest recorded outbreak 
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of S. suis serotype 2 infection which involved 215 cases and 39 deaths, occurred in Sichuan 
Province, China. Three clinical features which were sepsis, meningitis and streptococcal toxic 
shock syndrome (STSS) were observed in this outbreak (Yu et al., 2006). All patients were 
backyard pig farmers who were exposed to S. suis via direct contact with blood or tissue of 
infected pigs during slaughtering process (Yu et al., 2006). Sporadic human cases have also 
commonly occurred in many countries. The main S. suis infection route in human is by direct 
contact with carrier pigs, sick pigs or contaminated pork via injured skin or injured mucosa. 
Thus, S. suis infection in human is an occupational disease and the persons who work in close 
contact with pigs, such as pig farmers, abattoir and meat-processing workers, and 
veterinarians, have a high risk (Lun et al., 2007). Moreover, S. suis was isolated from 6.1% of 
raw pork from 3 of the 6 wet markets in Hong Kong (Ip et al., 2007) and human S. suis 
infections reported from Thailand and Vietnam were often caused by the consumption of raw 
or undercooked pork, pigs’ blood or their products (Fongcom et al., 2009; Nghia et al., 2011; 
Takeuchi et al., 2012). In addition to direct contact with pigs, the processing and consuming 
of uncooked pork or pork products are risk factors for the infection.  
Meningitis is the most common clinical feature in human S. suis infection, whereas 
septicemia, endocarditis, arthritis, peritonitis, pneumonia, uveitis and endopthalmitis have 
also been reported (Segura, 2009). Mild to severe hearing loss is one of the distinct sequelae 
after recovery from meningitis and the prognosis for hearing is guarded (Wertheim et al., 
2009). Although the haemorrhagic labyrinthitis detected by magnetic resonance imaging was 
suggested to be the cause of deafness in S. suis meningitis patient (Tan et al., 2010), the exact 
cause of deafness remains unknown (Choi et al., 2012; Gottschalk et al., 2007). Not only 
serotype 2 which is the most common cause in human infection, serotypes 1, 4, 5, 14, 16 and 
24 have also been reported in the patients (Kerdsin et al., 2011; Nghia et al., 2008; Takeuchi 
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et al., 2012; Wertheim et al., 2009). Undoubtedly, S. suis, a major cause of human bacterial 
meningitis in Asian countries, is considered to be an important emerging zoonotic pathogen. 
The virulence factors of S. suis have intensively been studied in the last few decades 
and many potential virulence factors have been identified including capsule, muramidase-
released protein (MRP) (Smith et al., 1992), extracellular protein factor (EF) (Vecht et al., 
1992), suilysin (Jacobs et al., 1994), several adhesins (Baums & Valentin-Weigand, 2009), 
and hyaluronate lyase (Allen et al., 2004). Although the precise role of MRP and EF is not 
clearly identified, these putative virulence factors are frequently associated with highly 
virulent serotype 2 strains and commonly served as virulence markers in some parts of the 
world (Fittipaldi et al., 2012; Silva et al., 2006).  
Each putative virulence factor was proposed to play a role in each step of the 
pathogenesis of the infection. Due to the requirement of adhesion during colonization, 
adhesins such as fibronectin- and fibrinogen-binding protein (Fbps) (de Greeff et al., 2002), 
enolases (Esgleas et al., 2008) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
(Brassard et al., 2001; Brassard et al., 2004) are potentially involved in the virulence. After 
entering blood circulation, capsule which has been proved to protect the bacterial cells from 
host immune system is required for the bacterial survival and dissemination (Fittipaldi et al., 
2012). On the basis of the mutagenesis technique and the virulence attenuation of knockout 
mutants in the different experimental infection models, many factors or genes were 
additionally proposed to drive the full virulence of S. suis strains (Aranda et al., 2010; Pan et 
al., 2009; Vanier et al., 2009; Wilson et al., 2007; Zhang et al., 2010). Moreover, a candidate 
pathogenicity island was proposed from the sequencing of the highly invasive S. suis serotype 
2 strains from Chinese outbreak (Chen et al., 2007). However, the putative virulence factors 
mostly exist in both virulent and avirulent strains and there may not be a universal virulence 
7 
 
factor for all S. suis strains (Fittipaldi et al., 2012). Therefore, multiple virulence factors are 
essential for S. suis to achieve the infection.  
Among the virulence determinants which have been described so far, capsular 
polysaccharide (CP) is thought to play an important role for effective systemic infection in 
various species of bacteria including S. suis and other streptococci (Corbett & Roberts, 2009). 
However, the unencapsulated and nontypeable streptococci have increasingly been isolated 
from clinical cases (Bonifait et al., 2010; Crum et al., 2004; Martin et al., 2003; Melchiorre et 
al., 2012; Sellin et al., 1992). Katsumi et al. (1997) reported that 61.6% of S. suis isolates 
from slaughtered pigs with endocarditis were untypeable. Unlike isolates from other types of 
S. suis diseases, it was noticed that many S. suis isolates from pigs with endocarditis which 
possessed serotype 2 (or 1/2)-specific gene could not be agglutinated with either anti-serotype 
1 or anti-serotype 2 sera, suggesting that these isolates may have frequently lost their ability 
to synthesize capsule. Although the unencapsulated and nontypeable S. suis isolates have 
previously been reported, the cause of unencapsulation and characteristics of these isolates 
remained largely unknown. Therefore, it is very interesting to elucidate the mechanism of this 
phenomenon. 
This study aims to verify the loss of capsule, which occurs in many S. suis isolates 
from porcine endocarditis cases. In addition, for better understanding of the unencapsulation 
mechanism and its biological significance, the genetic backgrounds and potential benefit of 
the unencapsulation in the pathogenesis of infective endocarditis are investigated. The results 
from this study additionally demonstrate the regions in a capsular polysaccharide synthesis 
(cps) gene cluster in which there are the mutations related to the viability of S. suis and the 
potential benefit of the unencapsulation to facilitate the persistence of S. suis in host and the 
establishment of the infection. 
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Chapter 1 
 
Loss of capsule in S. suis isolates from porcine endocarditis  
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1.1. Introduction 
Streptococcus suis is a zoonotic pathogen that causes serious diseases, including 
meningitis, arthritis, septicemia and endocarditis, in swine and humans (Gottschalk et al., 
2007). S. suis strains are classified into different serotypes according to the antigenicity of 
their CPs (Higgins & Gottschalk, 2006). Among them, serotype 2 has been predominantly 
isolated from both infected pigs and patients in many countries (Wertheim et al., 2009). 
Production of S. suis capsule is mediated by cps genes clustered in a single locus of the 
genome. Among the genes in the cps gene clusters identified to date (Holden et al., 2009; 
Okura et al., 2013; Smith et al., 1999a; Smith et al., 2000), cps2J existed only in strains of 
serotypes 2 and 1/2; therefore, this gene is sometimes used as a molecular marker of the two 
serotypes (Smith et al., 1999c). However, for determination of the serotypes, it is necessary 
to verify their phenotypes by serotype-specific antisera. 
Endocarditis caused by S. suis is often found in adult pigs, particularly in slaughter 
houses. In Japan, most of the endocarditis isolates are cps2J-positive by PCR (unpublished 
observation), suggesting that they are serotype 2 or 1/2. However, more than 50 % of the S. 
suis isolates from porcine endocarditis were shown to be untypeable by agglutination tests 
(Katsumi et al., 1997), whereas a high percentage of isolates from meningitis and pneumonia 
were serotypeable (Kataoka et al., 1993). Although the polysaccharide capsule is believed to 
be essential for the virulence of S. suis (Benga et al., 2008; Chabot-Roy et al., 2006; 
Charland et al., 1998), these observations imply that many endocarditis isolates, especially 
those of serotypes 2 and 1/2, often lose their ability to synthesize capsules. 
For confirmation of this speculation, in this chapter, the capsular production of cps2J-
positive isolates from endocarditis and meningitis is investigated. Furthermore, the genetic 
backgrounds of 43 representative unencapsulated isolates are examined.  
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1.2. Materials and methods 
1.2.1. Bacterial isolates, strains, and growth conditions 
 A total of 288 cps2J-positive S. suis isolates from different pigs were used in this 
study. Among them, 256 isolates were isolated from heart valve vegetations of pigs with 
endocarditis in regional Livestock Hygiene Service Centers in Japan between 1994 and 2009. 
Thirty-two isolates, including well-characterized strain P1/7 (Slater et al., 2003), were from 
pigs with meningitis. Except P1/7, all of the meningitis isolates were isolated in regional 
Livestock Hygiene Service Centers or National Institute of Animal Health in Ibaraki, Japan 
between 1989 and 2006. All isolates were stored in Luria-Bertani (Difco Laboratories, 
Becton Dickinson, Sparks, Maryland, U.S.A.) broth containing 30% glycerol at -80 ºC and 
minimally passaged for the experiments to avoid changing the key traits including capsule 
production. In addition, S. suis strains 204 (serotype 1 field isolate) (Sekizaki et al., 2001) 
and S735 (NCTC 10234
T
; serotype 2 reference strain) were used for the production of rabbit 
antiserum. Enterococcus faecalis NCTC 775 was used as a control for PCR analysis. S. suis 
and E. faecalis were cultured in Todd Hewitt broth (THB; Difco Laboratories) or agar (THA) 
at 37 ºC in air plus 5 % CO2 for 16 h. Escherichia coli strain was cultured in Luria-Bertani 
(Difco Laboratories) broth or agar at 37ºC. When required, spectinomycin was added to the 
medium for E. coli at 50 µg/ml and for S. suis at 100 µg/ml.   
 
1.2.2. Confirmation of S. suis and cps2J-positive S. suis isolates 
Identification of S. suis field isolates was confirmed by species-specific PCR for S. 
suis that targeted the glutamate dehydrogenase gene (gdh) (Okwumabua et al., 2003) or 
sequencing of the 16S rRNA gene. The presence of cps2J was determined by PCR as 
described previously (Silva et al., 2006). Template DNA was prepared by InstaGene Matrix 
(Bio-Rad Laboratories, Hercules, California, U.S.A.), and PCR reactions were performed 
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using Ex Taq polymerase (Takara Bio, Otsu, Shiga, Japan) following the manufacturers’ 
recommendations. Primers used for gdh and cps2J amplifications and expected size of PCR 
products are shown in Table 1.1. The following PCR cycling was used; started at 94ﾟC for 2 
min, repeating 30 cycles of 94ﾟC for 20 sec, 55ﾟC (for gdh) or 58ﾟC (for cps2J) for 10 sec, 
72ﾟC for 30 sec and final extension at 72 ºC for 1 min. The PCR products were visualized by 
electrophoresis on 1% agarose gel following standard procedures. 
 
1.2.3. Production of rabbit antisera 
Rabbit anti-serotype 1 and anti-serotype 2 polyclonal sera were prepared by 
immunizing rabbits with formalin-killed S. suis strains 204 and S735, respectively, according 
to the procedure described previously (Higgins & Gottschalk, 1990). Briefly, rabbits 
weighing 3 kg were given 3 injections per week of increasing numbers of bacteria during 4 
weeks as follows: first week, 2-4 x 10
9
 CFU; second to fourth week, 4-8 x 10
9
 CFU. Ten days 
after the last injection, blood samples were collected and the sera were evaluated by 
coagglutination tests as described below. All animal procedures were carried out according to 
the regulations and guidelines approved by the Animal Ethics Committee of the National 
Institute of Animal Health. 
 
1.2.4. Serotyping 
The capsular antigens of all cps2J-positive isolates cultured on THA plates were 
extracted by autoclaving the cells in Dulbecco’s phosphate-buffered saline (DPBS) at 121 ºC 
for 15 min and tested with anti-serotypes 1 and 2 sera. The coagglutination technique was 
applied as previously described (Gottschalk et al., 1989; Han et al., 2001). The capsular 
antigen and coagglutination reagent were mixed on black paper slide and the reaction was 
judged as positive when agglutination occurred within 5 min. As for isolates with a negative-
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agglutination reaction, further coagglutination tests were performed to verify the absence of 
capsule using isolates subcultured under the condition recommended to enhance capsular 
production (Gottschalk et al., 1993).  
 
1.2.5. Transmission electron microscopy (TEM) 
The samples were prepared according to previous studies (Jacques et al., 1990; 
Mackie et al., 1979) with some modifications. Briefly, bacterial cells were harvested from 
cultures on the THA plate, washed with phosphate-buffered saline (PBS, 0.01 M, pH 7.2), 
and incubated with anti-serotype 2 serum at 4 ºC for 1 h. The cells were then washed with 
deionized distilled water (DDW) and fixed with 5 % (v/v) glutaraldehyde containing 0.15 % 
(w/v) ruthenium red at room temperature for 2 h. The cells were immobilized in 1 % agar, 
postfixed with 1 % osmium tetroxide at 4 ºC for 1.5 h, and washed once with DDW. Samples 
were then dehydrated with a graded series of ethanol and embedded in low-viscosity resin 
(Quetol 651 mixture; Nisshin EM, Tokyo, Japan). Ultrathin sections were stained with uranyl 
acetate and lead citrate prior to examination with a transmission electron microscope (H-
7500; Hitachi, Tokyo, Japan).  
 
1.2.6. PCR analysis of genes in the cps gene clusters and sequencing of mutated regions 
Twenty-one primer sets covering the almost entire cps gene cluster of serotype 2 
(cps2A-2S) (Table 1.2 and Figure 1.1) were designed on the basis of the S. suis strain P1/7 
genome sequence data (accession number AM946016). Chromosomal DNA extracted by 
standard procedures (Mogollon et al., 1990) was used as template DNA, and PCR reactions 
were performed using Ex Taq polymerase (Takara Bio) according to the manufacturer’s 
instructions. The conditions of the PCR analysis consisted of pre-denaturing at 95 ºC for 5 
min, 30 cycles of 20 sec at 95 ºC, 10 sec at 55 ºC, 1 min at 72 ºC, and final extension at 72 ºC 
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for 2 min. Chromosomal DNA of S. suis P1/7 and E. faecalis NCTC 775 was used as positive 
and negative controls, respectively. PCR products were analyzed by electrophoresis on 1 % 
agarose gel and/or a MultiNA microchip electrophoresis system (Shimadzu Corporation, 
Kyoto, Japan).  
The PCR products of sizes different from those of S. suis P1/7 were purified by a 
QIAquick PCR purification kit (Qiagen, Hilden, Germany) following the manufacturer’s 
instructions and sequenced by primer walking. Additional PCR and inverse PCR (Ochman et 
al., 1988) using different combinations of primers were performed to amplify the altered cps 
regions. For the isolates which gave expected PCR amplifications, LA Taq and Ex Taq 
polymerase (Takara Bio) were used for amplification of genes in their cps gene clusters. The 
PCR products were sequenced by a BigDye terminator v3.1 cycle sequencing kit using a 
3130xl Genetic Analyzer (Applied Biosystems, Foster City, California, U.S.A.). Sequencher 
Ver. 4.8 (Hitachi Software Engineering, Yokohama, Japan) and Artemis software (Wellcome 
Trust Sanger Institute, http://www.sanger.ac.uk) were used for assembly and analysis of the 
sequences. Deletions and insertions were determined using the CLUSTALW Ver. 1.83 
(http://clustalw.ddbj.nig.ac.jp/top-e.html) and BLAST 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) programs. In addition, IS Finder (http://www-
is.biotoul.fr/) was used to annotate and classify insertion sequence (IS) elements. 
 
1.2.7. Bacterial strains, plasmid, primers and DNA techniques for the construction of 
cps gene expression vectors and complementation analysis 
 Plasmids and bacterial strains used for the construction of expression vectors are 
listed in Table 1.3. Genomic DNA of S. suis was extracted as described previously (Mogollon 
et al., 1990), and plasmid DNA of E. coli was purified using the Illustra™ plasmid Prep Mini 
Spin Kit (GE Healthcare, Freiburg, Germany) according to the manufacturer’s 
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recommendations. Restriction enzymes and DNA-modifying enzymes were purchased from 
Takara Bio and used according to the manufacturer’s recommendations. The transformation 
of E. coli was carried out following the standard procedures (Sambrook & Russell, 2001) and 
S. suis was transformed by electroporation as described previously (Takamatsu et al., 2001b). 
For construction of cps2E, cps2F, and cps2K expression vectors, designated pCps2E, 
pCps2F, and pCps2K, respectively, the entire cps2E, cps2F, and cps2K genes were amplified 
from genomic DNA of S. suis strains P1/7 and/or 89/1591 by PCR with primers listed in 
Table 1.4 and iProof HF Master mix (Bio-Rad Laboratories), digested by BamHI and EcoRI 
(for pCps2E and pCps2F) or PstI and EcoRI (for pCps2K), and cloned into the respective 
sites of pMX1. For construction of the cps2F-cps2K expression vector, designated pCps2F-
2K, cps2F and cps2K were individually amplified by PCR with the primers listed in Table 
1.4, fused by overlap-extension PCR (Warrens et al., 1997), and subsequently cloned into 
pMX1 via PstI and EcoRI sites. After introducing E. coli strain MC1061, the direction and 
sequences of the cloned genes were verified by PCR and sequencing. The resultant 
expression vectors were then introduced into unencapsulated S. suis isolates, and restoration 
of the capsular expression was examined by the coagglutination test and TEM. 
  
1.3. Results 
1.3.1. Loss of capsule in cps2J-positive endocarditis isolates 
 A total of 288 isolates which were confirmed to be cps2J-positive S. suis were 
examined for capsular production by the coagglutination test. All 32 isolates from meningitis 
exhibited agglutination with anti-serotype 2 serum, and among them, four were also 
agglutinated with anti-serotype 1 serum, indicating that the 28 and 4 isolates were serotypes 2 
and 1/2, respectively. In contrast, although 170 (66 %) isolates from endocarditis were 
agglutinated with anti-serotype 2 serum, 86 (34 %) isolates were not agglutinated with either 
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anti-serotype 1 or anti-serotype 2 sera, suggesting that these isolates have lost their capsule. 
The two coagglutination-positive (P1/7 and NL333) and four coagglutination-negative 
(NL146, NL194, NL240 and NL290) strain and isolates were selected and examined visually 
by TEM to confirm the coagglutination results. As shown in Figure 1.2, cells of both 
coagglutination-positive strain and isolate were surrounded by a thick capsule, whereas no 
capsular material could be seen in the coagglutination-negative isolates. These results 
demonstrate that, unlike meningitis isolates, notable numbers of endocarditis isolates lose 
their ability to produce the capsule.  
 
1.3.2. Structural alterations occurred in the cps gene clusters of the unencapsulated      
isolates 
 For investigation of the genetic backgrounds affecting capsular expression, 43 
representative unencapsulated isolates were randomly selected and analyzed for their genes in 
cps gene clusters by PCR analysis. As shown in Table 1.5, 18 isolates gave no or unexpected 
amplification with at least one of the primer sets (Figure 1.3), indicating structural alterations 
in the cps gene clusters. Nucleotide sequencing of those regions showed that genes in the cps 
gene clusters of 8 and 10 isolates had deletions and insertions, respectively (Figure 1.4). 
However, no apparent alteration was found in the cps regions of the other 25 isolates by PCR 
analysis. 
Three isolates (NL157, NL191 and NL280) had a partial deletion in the cps2P, cps2E, 
and cps2G genes, respectively, whereas five (NL204, NL217, NL268, NL290, and NL319) 
had a deletion of multiple genes, as shown in Figure 1.4. Among the five isolates above, a 
large deletion (more than 17.5 kb fragment including the cps2P, cps2Q, cps2R and cps2S 
genes) was found in NL217. In addition, this isolate had a 192-bp deletion in the cps2F gene. 
In NL204 and NL290, more than 3-kb deletions were found in almost the same region 
16 
 
(cps2A, cps2B, cps2C, cps2D and cps2E genes), while SSU0514-cps2A and cps2F-G regions 
were lost in NL268 and NL319, respectively. 
IS or putative IS elements also disrupted cps genes (Figure 1.4 and Table 1.6). The IS 
elements found in NL85 and NL194 were classified into the ISL3 family, while those of 
NL155, NL171, NL198, NL201 and NL255 were classified into the IS110 family. Although a 
putative IS element found in NL184 did not show significant similarity to any other known IS 
elements by means of blastn search, the closest relative was proposed to be ISTel1 of 
Thermosynechococcus elongatus BP-1, which belongs to the IS481 family (Nakamura et al., 
2002) by the IS finder search. However, the sequences inserted in the cps gene clusters of 
NL176 and NL179 encoded putative reverse transcriptases that constitute group II introns 
(Michel & Ferat, 1995). 
 Notably, most of the deletion and insertion were found in the cps2A-2G and cps2P-
cps2S regions, particularly in cps2E, as 7 of 10 insertions were found in this gene. On the 
other hand, the cps2H- cps2O region of the isolates analyzed was rarely affected. 
 
1.3.3. Capsule loss in S. suis isolates due to mutations in cps2EF  
 The entire cps2 gene clusters (cps2A-2S) of three representative isolates (NL119, 
NL257, and NL278) were sequenced to reveal the potential cause of unencapsulation of the 
25 endocarditis isolates that gave expected PCR amplifications. Compared with the sequence 
of S. suis strain P1/7, NL257 had a 4-bp insertion resulting in frameshift mutation in cps2E, 
and the other two had single nucleotide substitutions in cps2F, leading to single amino acid 
substitutions of the gene products (Figure 1.5 and Table 1.7), whereas the other genes in the 
clusters were intact. For investigation whether these mutations impeded capsular production, 
NL257 was transformed with pCps2E and NL119 and NL278 were transformed with 
pCps2F. In all three transformants, the coagglutination test using anti-serotype 2 serum 
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showed positive reactions, and TEM analysis confirmed the distinct layer of capsule on the 
cell surfaces, whereas capsular material was not obviously seen on the surface of cells from 
the parent strains (Figure 1.6), which affirmed that mutations in the cps2EF region caused 
capsule loss in the three isolates.  
Because these results together with the results described above (1.3.2) implied that 
mutations affecting capsular production may often occur in the cps2EF region, genes of the 
cps2EF region of the remaining 22 unencapsulated isolates were sequenced and compared 
with those of S. suis strains P1/7 and 89/1591 (accession no.: AAFA03000010). As shown in 
Figure 1.5, six and four of the 22 isolates had frame shift mutations in cps2E and cps2F, 
respectively, while single nucleotide substitutions within cps2E and cps2F were found in two 
and five isolates, respectively. Among the seven nucleotide substitutions, three created 
termination codons (nonsense mutations), and the other four generated amino acid 
substitutions (missense mutations). The cps2EF sequencing results additionally showed that 
one isolate carried 81-bp deletion in cps2F and only four isolates had intact cps2E and cps2F. 
The complementation analyses by introducing pCps2E or pCps2F to the isolates and 
examining the capsular expression by coagglutination test were subsequently performed to 
verify that the mutations found in cps2EF region were responsible for the unencapsulation. 
Because nonsense mutations found in three isolates, frameshift mutations found in seven 
isolates, and an 81-bp deletion found in one isolate resulted in truncation or significant 
shortening of the products, these mutations were supposed to be involved in their loss of 
capsule; therefore, only two isolates (NL100 and NL240) were investigated. On the other 
hand, because frameshift mutations due to the deletion of four bases (TAAG) at the site of the 
termination codon of cps2E found in three isolates (NL208, NL219 and NL342) resulted in 
the extension of Cps2E, these three were included for the analysis to verify influence of the 
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putative structural conformation change of Cps2E. All missense mutations were also 
investigated. 
As shown in Figure 1.5, except for NL208, from which no transformant was obtained, 
all isolates with nonsense or frameshift mutations showed positive coagglutination reactions 
after the introduction of pCps2E or pCps2F, which indicated that these nonsense and 
frameshift mutations in the cps2EF region caused capsule loss of the isolates. Among four 
isolates carrying missense mutations, transformants from two isolates (NL122 and NL295) 
showed positive coagglutination reactions, indicating that at least two of the four missense 
mutations affected function of the genes. However, because transformants from the other two 
isolates with missense mutations (NL132 and NL143) gave negative coagglutination results, 
the cause of unencapsulation in these two as well as four isolates (NL174, NL175 NL322, 
and NL345), which carried intact cps2E and cps2F, was unclear. Therefore, the almost entire 
cps gene clusters of the six isolates were further sequenced. As shown in Figure 1.7, NL174 
and NL175 had the same single frameshift mutation in cps2H, while NL322 and NL345 had 
50-bp and 23-bp deletions in cps2G and cps2H, respectively, suggesting that these mutations 
caused loss of their capsule. In addition to the mutations in the cps2EF region, NL132 had 
another frameshift mutation in cps2H, while NL143 harbored a 9-bp insertion in cps2K, 
leading to the duplication of three amino acid residues (Asn His Trp) within Cps2K. Because 
the capsule of NL143 was restored only after introduction of both intact cps2F and cps2K, the 
capsule loss in NL143 was indicated to result from mutations in both cps2F and cps2K. 
These results together with the results described in 1.3.2 indicated that at least 32 
(74.4%) of 43 representative unencapsulated isolates have lost their capsules because of the 
mutations in cps2EF region (Table 1.8). These facts confirmed that mutations in the cps2EF 
region caused unencapsulation in most of the S. suis isolates from porcine endocarditis. 
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1.4. Discussion 
In addition to the molecular basis for serotyping in S. suis (Higgins & Gottschalk, 
2006), polysaccharide capsule has been shown to be an important virulence factor of this 
pathogen. Compared with the parent strains, the isogenic unencapsulated mutants of S. suis 
serotype 2 were more susceptible to phagocytosis by both macrophages and neutrophils 
(Benga et al., 2008; Chabot-Roy et al., 2006; Charland et al., 1998). Moreover, capsule loss 
reduced the virulence of S. suis in both mice and swine models of infection (Smith et al., 
1999a). However, in this chapter, approximately one third of the endocarditis isolates from 
swine were demonstrated to lose the ability to produce capsules. Therefore, it is suggested 
that the loss of capsule in these isolates may provide some advantageous properties to the 
pathogenesis of infective endocarditis in swine.  
Because encapsulated isolates were retrieved from 66 % of the porcine endocarditis 
cases analyzed in this study, even in cases from which unencapsulated S. suis were isolated, it 
is unknown whether all bacterial cells present in the vegetations were unencapsulated or 
whether only a subpopulation of infected bacteria lost the capsule and the unencapsulated 
cells established a footing as the first colonizers for further colonization of encapsulated cells. 
It is also unclear whether unencapsulation occurred after invasion of the bloodstream by 
bacteria or whether unencapsulated strains can be transmitted among different pigs and 
farms. Interestingly, the five isolates (NL155, NL171, NL198, NL201, and NL255) with 
almost the same IS elements (99.8-100 % identical at the nucleotide level) at the same 
position of cps2E (Figure 1.4 and Table 1.6) were found in this study. Among them, NL155, 
NL171, NL198, and NL201 were isolated from different pigs in the same prefecture, while 
NL255 was isolated from the adjacent area. This may suggest the transmission of 
unencapsulated S. suis strains among pigs and farms, although the possibility that the inserted 
position was the preferential site for the IS elements and insertion events occurred 
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independently in each isolate cannot be completely ruled out. Notably, most of the deletion 
and insertion found in the unencapsulated isolates occurred in the cps2A-2G region. Among 
the genes in this region, cps2E was the most frequently altered. This may support the notion 
that cps2E and its flanking regions are hot spots for structural alteration.  
No apparent deletion or insertion was detected by PCR analysis in the 25 
unencapsulated isolates. As previously reported by Willenborg et al. (2011), the catabolite 
control protein A (CcpA) of S. suis is necessary for capsular expression and that deletion of 
ccpA resulted in significant reduction of capsule thickness. However, deduced amino acid 
sequences of ccpA of the 25 unencapsulated isolates were 99.4-100% identical to that of 
strain P1/7 and 99.7-100% identical to that of strain 89/1591 (unpublished observations), 
suggesting that ccpA of the unencapsulated isolates was intact. Therefore, their cps gene 
clusters may be affected by point mutations that could not be detected by PCR analysis. As 
expected, the sequencing and complementation results of the remaining 25 isolates showed 
that most of them had nucleotide alterations of a single or a few base pairs in the cps2EF 
region, causing frameshift, missense or nonsense mutation(s) of the genes. 
Alternatively, it is conceivable that their capsular expression was negatively regulated 
by unknown mechanisms. In fact, phase variation of the capsular expression has previously 
been reported in a group B Streptococcus (GBS) isolate. In this case, although the original 
strain isolated from the blood of a patient with endocarditis was unencapsulated, encapsulated 
variants could be recovered after Percoll gradient centrifugation (Sellin et al., 1992). Similar 
phase variations were found in other Gram-positive and -negative bacteria (van der Woude & 
Baumler, 2004). Although such variations have not been reported in S. suis, capsular 
expression may be reversible in some unencapsulated S. suis isolates. Moreover, even in 
unencapsulated isolates, which had mutations affecting capsular expression, capsule 
production could be restored by acquiring functional genes via horizontal gene transfer, 
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additional point mutations, and the excision of inserted sequences. Further studies to 
investigate the above possibilities will provide additional insights into the role of the capsule 
in the pathogenesis of S. suis infection. 
It is noteworthy that the cps gene clusters of NL176 and NL179 were similarly 
disrupted by the insertion of putative group II intron within cps2M. Because cps2M is 
considered to be a pseudogene, it cannot be assumed that the disruption of cps2M itself 
caused the loss of capsular production in these isolates. Thus, in the two isolates, additional 
point mutations and/or negative regulation of capsular expression may have occurred in 
addition to the insertion events. Alternatively, the expression of downstream genes may have 
been affected by a polar effect caused by insertion of the group II intron. 
Although the capsule is thought to be an important virulence factor for S. suis, the 
results in this chapter demonstrated that about 34% of the endocarditis isolates from swine 
lost the ability to produce capsule. According to the results from PCR analysis, sequencing 
and complementation, at least 32 of 43 representative unencapsulated isolates have lost their 
capsules because of the mutations involving cps2EF region.  
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1.5. Summary 
In this chapter, 288 cps2J-positive S. suis isolates from diseased pigs (256 from 
endocarditis and 32 from the brains or meningitis) were analyzed. All isolates from 
meningitis were shown to be encapsulated by coagglutination tests and TEM, whereas 86 
isolates (34%) from endocarditis were identified to be unencapsulated. Among 43 
unencapsulated endocarditis isolates that were randomly selected for PCR analysis, 10 and 8 
isolates were demonstrated to have apparent insertions and deletions, respectively, in their 
cps gene clusters. The cps gene clusters of the rest of 25 isolates were analyzed by 
sequencing and complementation. The results demonstrated that at least 32 of 43 
representative unencapsulated isolates have lost their capsules because of the mutations in 
cps2EF region. Intriguingly, the mutation within the cps2IJ and cps2NO regions was rarely 
found in the isolates analyzed in this study. Since capsule is considered as a virulence 
determinant in S. suis, the unencapsulation due to these structural alterations may provide 
some benefits to cause endocarditis in swine. 
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Table 1.1. Primers used for gdh and cps2J amplifications and expected size of PCR products. 
Target 
gene 
Primer Sequence 
Expected size 
of PCR 
product 
gdh 
Forward 5'-GCAGCGTATTCTGTCAAACG-3' 
688 bp 
Reverse 5'-CCATGGACAGATAAAGATGG-3' 
cps2J 
Forward 5'-TTTGTCGGGAGGGTTACTTG-3' 
498 bp 
Reverse 5'-TTTGGAAGCGATTCATCTCC-3' 
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Table 1.2. Primer sets for PCR analysis. 
Primer pairs Forward Sequence (5'-3') Reverse Sequence (5'-3') 
 
Product size 
in strain P1/7 
 
1 cps2-F1 AGGTAAAAGTCTAGGAAGGT cps2-R1 ACGGACTGAATCGCTGCCTT 1455 bp 
2 cps2-F2 TTAATCGACTTGGTGGGTGG cps2-R2 GAAGAAACCAGGCATGACTG 1451 bp 
3 cps2-F3 AGCGGAAGAACCAACCACTC cps2-R3 CGCCAATTAAAGCAGGCTTC 1441 bp 
4 cps2-F4 CGAAGCTTATCGTCAAGGTG cps2-R4 TCATCAAGATGTGACTAGGC 1472 bp 
5 cps2-F5 CGTGGTGCCGTGTATTTCAC cps2-R5 CATGACCGTCTGGGTTTACG 1520 bp 
6 cps2-F6 GGACCATCTGGTCAGACATT cps2-R6 CCTACGTAGAATTGGATAGT 1476  bp 
7 cps2-F7 GGAACGAACCCATCTTTACT cps2-R7 ACTTTGAGGGAGGTGTAGAC 1412 bp 
8 cps2-F8 GAGTGGCGAGTAGTAGAATT cps2-R8 CGATATTGTTCTCCATAGTAGC 1490 bp 
9 cps2-F9 GAGGCATATAATCAGTATCG cps2-R9 TTGCTGACATATTCCGATAG 1492 bp 
10 cps2-F10 GGTACAGGTGTAGACTTGTC cps2-R10 GTTGATTCCATAGTAGATATAG 1422 bp 
11 cps2-F11 TGATTCTTACGCTCATCGCG cps2-R11 AGAGGACGTTCGTTTAATAC 1480 bp 
12 cps2-F12 AAGAGGTGCGAGACTTAGGA cps2-R12 AAGCTTCTTTTGCTGTTTGC 1398 bp 
13 cps2-F13 TCAGGCTGTTCTGAGCGGCA cps2-R13 ATTGCTGGAATCTTCTGTCC 1449 bp 
14 cps2-F14 ATCGGGTCCAGGGAGTTGGG cps2-R14 GGATCTGATACATCGTATGG 1464 bp 
15 cps2-F15 TCAGAAATGTATAAGGGGGG cps2-R15 GTTCCAATCGTATAGACGAG 1481 bp 
16 cps2-F16 AGCAAGGGCGATAGTAGCGG cps2-R16 CAGATAGGAAGCAGTCGTTG 1566 bp 
17 cps2-F17 TGGGCTTCATTTTCGAAAGG cps2-R17 GGTATTCTGCCTTTGGTGCG 1502 bp 
18 cps2-F18 CTCTACCATGAAAATTGTGC cps2-R18 ATCCTACGCTTGTCCGCTTC 1552 bp 
19 cps2-F19 CTGGACAATGAAATGGAAGG cps2-R19 CATGGTTGAGGCCTGTACAG 1466 bp 
20 cps2-F20 GGAGGATAACACAGCCGAAG cps2-R20 CTAACAACGTGGTCAGCTTG 1533 bp 
21 cps2-F21 CAGTGATTCAATGTATCGAG cps2-R21 CCAACATAGTCTAGCCACTG 1400 bp 
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Table 1.3. Bacterial strains and plasmids used in this study. 
 
 
Strain or plasmid Relevant characteristics Source or reference 
S. suis strains 
P1/7 Wild-type strain isolated from a pig with meningitis (Slater et al., 2003) 
89/1591 Wild-type strain isolated from a pig with septicemia and meningitis (Salasia et al., 1995) 
 
E. coli strain 
  MC1061 Host for pMX1 derivatives (Casadaban & Cohen, 
1980) 
 
Plasmids    
pMX1 Spc
r
, pSSU1 ori, the malX promoter of S. suis, the derivative of pSET2 (Okura et al., 2011) 
pCps2E pMX1 carrying the intact cps2E gene This study 
pCps2F pMX1 carrying the intact cps2F gene This study 
pCps2K pMX1 carrying the intact cps2K gene This study 
pCps2F-2K pMX1 carrying intact cps2F and cps2K genes This study 
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Table 1.4. Primers used for construction of cps gene expression vectors.  
 
Primer  Sequence (5'-3') Description PCR program
a
 
For construction of pCps2E 
pCps2E-F AAACGGATCCCAAGTACAGTAACCTCATAG BamHI site is underlined. 98
o
C 2min - 98
o
C 20sec, 60
o
C 
10sec, 72
o
C 1min (30 cycles) - 
72
o
C 2min pCps2E-R CACCGAATTCCCATACTTTGCTGGTATTCC EcoRI site is underlined. 
For construction of pCps2F 
pCps2F-F TTGTGGATCCAGGGAAGTAAGTAAGACTCC BamHI site is underlined. 98
o
C 2min - 98
o
C 20sec, 60
o
C 
10sec, 72
o
C 1min (30 cycles) - 
72
o
C 2min pCps2F-R TGCCCCATAGAATTCTGCTCCAGCATGGAG EcoRI site is underlined. 
For construction of pCps2K 
pCps2K-F TTACCTGCAGTATTAAACGAACGTCCTCTG PstI site is underlined. 98
o
C 2min - 98
o
C 20sec, 60
o
C 
10sec, 72
o
C 1min (30 cycles) - 
72
o
C 2min pCps2K-R TACTGAATTCTTACCGAGTACTACTTTCAC EcoRI site is underlined. 
For construction of pCps2F-2K 
1-pCps2FK GGAGATATGAGTCTAGTCGG For amplification of cps2F and its flanking regions 98
o
C 2min - 98
o
C 10sec, 55
o
C 
10sec, 72
o
C 1min (30 cycles) - 
72
o
C 2min 2-pCps2FK CCTACGTAGAATTGGATAGT For amplification of cps2F and its flanking regions 
3-pCps2FK AAGAGGTGCGAGACTTAGGA For amplification of cps2K and its flanking regions 98
o
C 2min - 98
o
C 10sec, 55
o
C 
10sec, 72
o
C 1min (30 cycles) - 
72
o
C 2min 4-pCps2FK ATTGCTGGAATCTTCTGTCC For amplification of cps2K and its flanking regions 
5-pCps2FK ATCTCTGCAGGCTGGACCTAACATACATTG 
Used for amplification of cps2F and generation of fused 
fragment to vector. PstI site is underlined.  
98
o
C 2min - 98
o
C 10sec, 60
o
C 
10sec, 72
o
C 1min (30 cycles) - 
72
o
C 2min 6-pCps2FK GCGATTCATCTCCATAATGCTGGCACTAGG 
Used for amplification of cps2F and generation of fused 
fragment to cps2K. 
7-pCps2FK CCTAGTGCCAGCATTATGGAGATGAATCGC 
Used for amplification of cps2K and generation of fused 
fragment to cps2F. 
98
o
C 2min - 98
o
C 10sec, 60
o
C 
10sec, 72
o
C 1min (30 cycles) - 
72
o
C 2min 8-pCps2FK TACTGAATTCTTACCGAGTACTACTTTCAC 
Used for amplification of cps2K and generation of fused 
fragment to vector. EcoRI site is underlined. 
a
 All PCRs were performed by using iProof HF Master mix (Bio-Rad Laboratories). 
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Table 1.5. PCR analysis results. 
Strain/ Isolate 
Primer pairs 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 
S. suis  P1/7 + + + + + + + + + + + + + + + + + + + + + 
            NL85 L L + + + + + + + + + + + + + + + + + + + 
            NL155 + + + L L + + + + + + + + + + + + + + + + 
            NL157 + + + + + + + + + + + + + + + + + S - + + 
            NL171 + + + L L + + + + + + + + + + + + + + + + 
            NL176 + + + + + + + + + + + + + - + + + + + + + 
            NL179 + + + + + + + + + + + + + - + + + + + + + 
            NL184 + + + L + + + + + + + + + + + + + + + + + 
            NL191 + + + + S - + + + + + + + + + + + + + + + 
            NL194 + + + L L + + + + + + + + + + + + + + + + 
            NL198 + + + L L + + + + + + + + + + + + + + + + 
            NL201 + + + L L + + + + + + + + + + + + + + + + 
            NL204 - - - - - + + + + + + + + + + + + + + + + 
            NL217 + + + + S S + + + + + + + + + + + - - - - 
            NL255 + + + L L + + + + + + + + + + + + + + + + 
            NL268 - - + + + + + + + + + + + + + + + + + + + 
            NL280 + + + + + - S + + + + + + + + + + + + + + 
            NL290 - - - - - + + + + + + + + + + + + + + + + 
            NL319 + + + + + - - - + + + + + + + + + + + + + 
           Other isolates
a + + + + + + + + + + + + + + + + + + + + + 
E. faecalis NCTC775 - - - - - - - - - - - - - - - - - - - - - 
 
+, PCR positive; -, PCR negative; L, amplified PCR products were larger than expected; S, amplified PCR products were smaller than expected.  
a
 Other isolates include S. suis NL100, NL119, NL122, NL126, NL132, NL143, NL146, NL174, NL175, NL208, NL219, NL225, NL230, NL240, NL245, 
NL249, NL257, NL266, NL278, NL295, NL303, NL322, NL328, NL342 and NL345. 
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Table 1.6. Inserted sequences in the cps gene clusters of unencapsulated isolates. 
Isolate 
Size of the  
inserted 
sequences 
(bp) 
Accession 
no. of the 
inserted 
sequences 
NCBI blastn results
a
 IS Finder blastp results
b
  
DR
c
 Nucleotide 
identity (%) 
Description and function of close relative 
[Accession no.] 
Amino acid 
identity (%) 
Description and function of close 
relative [Accession no.] 
NL85
d
 1,415 AB627103  
1412/1415 
(99%) 
Transposase, IS204/IS1001/IS1096/IS1165 
family protein of Streptococcus suis strain 
ST3 [CP002633] 
347/417 
(83%) 
Putative transposase of ISSth1 of 
Streptococcus thermophilus (ISL3 
family) [AY376237] 
8 
NL155
e
 1,619 AB627104  
 1617/1619 
(99%) 
Transposase of Streptococcus suis strain 
ST3 [CP002633] 
181/378 
(47%) 
Transposase of ISL4 of Lactobacillus 
delbrueckii subsp. bulgaricus (IS110 
family) [AY040213]  
4 
NL171
e
 1,619 AB627105  
1617/1619 
(99%) 
Transposase of Streptococcus suis strain 
ST3 [CP002633] 
181/378 
(47%) 
Transposase of ISL4 of Lactobacillus 
delbrueckii subsp. bulgaricus (IS110 
family) [AY040213] 
4 
NL176
f
 2,311 AB627106  
2297/2311 
(99%) 
Putative reverse transcriptase gene of 
Streptococcus agalactiae strain DSM2134 
[EF990366]  
564/568 
(99%) 
RNA-direct DNA polymerase of 
Streptococcus agalactiae strain ATCC 
13813 [EFV96300]
g 
 
0 
NL179
f
 2,311 AB627107  
2297/2311 
(99%) 
Putative reverse transcriptase gene of 
Streptococcus agalactiae strain DSM2134 
[EF990366] 
564/568 
(99%) 
RNA-direct DNA polymerase of 
Streptococcus agalactiae strain ATCC 
13813 [EFV96300]
g 
 
0 
NL184 1,115 AB627108  NSh NSh 
90/306 
(29%) 
Putative transposase of ISTel1 of 
Thermosynechococcus elongatus strain 
BP-1 [NC_004113]  
25 
NL194
d
 1,416 AB627109  
1376/1416 
(97%) 
Transposase, IS204/IS1001/IS1096/IS1165 
family protein of Streptococcus suis strain 
ST3 [CP002633] 
363/433 
(83%) 
Putative transposase of ISSth1 of 
Streptococcus thermophilus (ISL3 
family) [AY376237] 
8 
NL198
e
 1,619 AB627110  
1619/1619 
(100%) 
Transposase of Streptococcus suis strain 
ST3 [CP002633] 
181/378 
(47%) 
Transposase of ISL4 of Lactobacillus 
delbrueckii subsp. bulgaricus (IS110 
family) [AY040213] 
4 
NL201
e
 1,619 AB627111  
1617/1619 
(99%) 
Transposase of Streptococcus suis strain 
ST3 [CP002633] 
181/378 
(47%) 
Transposase of ISL4 of Lactobacillus 
delbrueckii subsp. bulgaricus (IS110 
family) [AY040213] 
4 
NL255
e
 1,619 AB627112  
1617/1619 
(99%) 
Transposase of Streptococcus suis strain 
ST3 [CP002633] 
181/378 
(47%) 
Transposase of ISL4 of Lactobacillus 
delbrueckii subsp. bulgaricus (IS110 
family) [AY040213] 
4 
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a
 The blastn analysis was performed on the NCBI website (http://blast.ncbi.nlm.nih.gov/Blast.cgi) using the inserted sequences.  
b
 The blastp analysis was performed on the IS finder website (http://www-is.biotoul.fr/) using the deduced amino acid sequences encoded in the inserted 
sequences.  
c
 DR indicates the number of target base pairs duplicated on insertion.  
d
 The inserted sequences were 97.3% identical but located at different positions.  
e The inserted sequences were 99.8-100% identical and located at the same position.  
f
 The inserted sequences were 100% identical and located at the same position.  
g
 NCBI blastp result.  
h
 NS, no significant similarity.  
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Table 1.7. Mutations found in 43 unencapsulated isolates analyzed in this study. 
 
No. Isolate Affected gene(s) 
Types of mutation or 
structural alteration  
Affected nucleotide(s)        
(Affected amino acid) 
1 NL85 cps2A Insertion IS element: 1415 bp 
2 NL100 cps2F Nonsense
b
  T696G      (Tyr232TERM) 
3 NL119
a
 cps2F Missense
b
  T490C      (Cys164Arg) 
4 NL122 cps2F Missense
b
  G52A        (Gly18Ser) 
5 NL126 cps2F Frame shift caused by insertion TCCG 
6 NL132
a
 cps2E Missense  G1199A    (Arg400Lys) 
  cps2H Frame shift caused by deletion TA 
7 NL143
a
 cps2F Missense
b
  G493T      (Asp165Tyr) 
  cps2K Insertion
b
 AATCATTGG (Asn His Trp) 
  cps2R Missense  G496A      (Gly166Arg) 
8 NL146 cps2F Nonsense  T482A      (Leu162TERM) 
9 NL155 cps2E Insertion IS element: 1619 bp 
10 NL157 cps2P Deletion 333 bp 
11 NL171 cps2E Insertion IS element: 1619 bp 
12 NL174
a
 cps2H Frame shift caused by deletion A 
13 NL175
a
 cps2H Frame shift caused by deletion A 
14 NL176 cps2M Insertion Putative group II intron: 2311 bp 
15 NL179 cps2M Insertion Putative group II intron: 2311 bp 
16 NL184 cps2E Insertion IS element: 1115 bp 
17 NL191 cps2E Deletion 68 bp 
18 NL194 cps2E Insertion IS element: 1416 bp 
19 NL198 cps2E Insertion IS element: 1619 bp 
20 NL201 cps2E Insertion IS element: 1619 bp 
21 NL204 cps2ABCDE Deletion 3215 bp 
22 NL208 cps2E Frame shift caused by deletion TAAG 
23 NL217 cps2F and cps2PQRS Deletion 192 bp and 17562 bp 
24 NL219 cps2E Frame shift caused by deletion
b
 TAAG 
25 NL225 cps2F Frame shift caused by insertion CCAAA 
26 NL230 cps2F Frame shift caused by insertion A 
27 NL240 cps2E Nonsense
b
  C1189T      (Gln397TERM) 
28 NL245 cps2E Frame shift caused by insertion T 
29 NL249 cps2E Frame shift caused by insertion AGCA 
30 NL255 cps2E Insertion IS element: 1619 bp 
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Table 1.7. (continued) Mutations found in 43 unencapsulated isolates analyzed in this study. 
 
No. Isolate Affected gene(s) 
Types of mutation or 
structural alteration  
Affected nucleotide(s)        
(Affected amino acid) 
31 NL257
a
 cps2E Frame shift caused by insertion
b
 ATCT 
32 NL266 cps2E Frame shift caused by deletion A 
33 NL268 cps2A Deletion 1953 bp 
34 NL278
a
 cps2F Missense
b
  T259C        (Ser87Pro) 
35 NL280 cps2G Deletion 410 bp 
36 NL290 cps2ABCDE Deletion 3538 bp 
37 NL295 cps2F Missense
b 
 T492G        (Cys164Trp) 
38 NL303 cps2F Deletion 81 bp 
39 NL319 cps2FG Deletion 1719 bp 
40 NL322
a
 cps2B Missense  G469A       (Asp157Asn) 
  cps2G Deletion 50 bp 
41 NL328 cps2F Frame shift caused by deletion AG 
42 NL342 cps2E Frame shift caused by deletion
b
 TAAG 
43 NL345
a
 cps2H Deletion 23 bp 
  cps2N Missense  C706T       (Pro236Ser) 
 
a
 All genes (cps2A-2S) in the cps gene clusters were sequenced.  
b
 Inactivating mutation (confirmed by complementation analysis). 
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Table 1.8. Mutations that critically affected the capsule synthesis of S. suis isolates found in 
this study. 
 
Position of the 
mutation 
Structural alteration 
Single nucleotide 
substitution 
Frameshift 
mutation 
Total 
Insertion Deletion Nonsense Missense  
In cps2E-2F  7 6
a
 3 5
b
 11 32 
Out of cps2E-2F  3 5 0 0 3
c
 11 
 
a
 Other cps genes were also deleted in four of the six isolates (NL204, NL217, NL290, and 
NL319).  
b
 A missense mutation in cps2R and an insertion in cps2K were also present in one of the five 
isolates (NL143). 
c
 Although one of the three isolates (NL132) had a missense mutation in cps2E, the mutation 
was not involved in the loss of the capsule. 
 
 
 3
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Figure 1.1. Genetic organization of serotype 2 cps gene cluster (Holden et al., 2009; Okura et al., 2013) and positions of primers used for PCR 
analysis. Gray arrows represent genes putatively involved in capsule synthesis. Black arrow indicates gene encoding hypothetical protein. Open 
arrows indicate pseudogenes or genes with unknown functions. Open and closed arrowheads represent forward and reverse primers, respectively. 
The latest cps gene names reassigned by Okura et al. (2013) were used in this figure. R, reaction numbers which correspond to the number of 
primer pairs.  
 
R1 R3
R4
R5
R6R2
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
SSU0514     cps2A     cps2B cps2C cps2D    cps2E        cps2F      cps2G            cps2H         cps2I       cps2J     cps2K cps2L                 cps2N     cps2O cps2P     cps2Q  cps2R   cps2S     SSU0539
cps2M 
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Figure 1.2. Transmission electron micrographs of ultrathin sections of S. suis strain and 
isolates. Cells of strain P1/7 (A) and isolate NL333 (B) were obviously surrounded by the 
capsule, while capsular materials were not seen in NL146 (C), NL194 (D), NL240 (E), and 
NL290 (F). Bar = 0.5 µm.   
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Figure 1.3. PCR analysis results of the six representative isolates examined by MultiNA 
microchip electrophoresis system. DNA extracted from NL176, NL179 and NL184 gave 
expected PCR amplifications, while the amplified product from NL191 was slightly smaller 
and the products from NL194 and NL198 were apparently larger than that amplified from 
positive control (S. suis strain P1/7).  
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Figure 1.4. Positions and types of structural alteration occurred in the cps2 gene clusters of representative unencapsulated endocarditis isolates. 
Gray arrows represent genes putatively involved in capsule synthesis. Black arrow indicates gene encoding hypothetical protein. Open arrows 
indicate pseudogenes or genes with unknown functions. Open triangles indicate positions of insertion. Gray lines indicate deleted regions.
NL85
NL157
NL176, 179
NL184
NL191
NL194
NL204
NL217
NL268
NL280
NL290
NL319
Insertion (IS element: 1415 bp)
Insertion (IS element: 1619 bp)
Deletion (333 bp)
Insertion (putative group II intron: 2311 bp)
Insertion (putative IS element: 1115 bp)
Deletion (68 bp)
Insertion (IS element: 1416 bp)
Deletion (3215 bp)
Deletion (192 bp) Deletion (17562 bp)
Deletion (1953 bp)
Deletion (410 bp)
Deletion (3538 bp)
Deletion (1719 bp)
Isolates
NL155, 171, 
198, 201, 255
SSU0514     cps2A     cps2B cps2C cps2D    cps2E        cps2F      cps2G            cps2H         cps2I       cps2J     cps2K cps2L                 cps2N     cps2O cps2P     cps2Q  cps2R   cps2S     SSU0539
cps2M 
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Figure 1.5. Sequencing results of genes in cps2EF region of 25 unencapsulated isolates. 
Closed triangles indicate the positions of mutations. Open circles and diamonds indicate 
missense and nonsense mutations, respectively. Open triangles and open rectangles indicate 
frame shift mutations caused by insertions and deletions, respectively. The closed rectangle 
represents the deleted region. 
a
 The isolates could be complemented with pCps2F. 
b
 The 
isolates could be complemented with pCps2E. 
c
 The isolate could not be complemented with 
pCps2E. 
d
 The isolate could not be complemented with pCps2F. 
e
 Because no transformant 
was obtained, complementation of cps2E could not be accomplished.  
NL303 81-bp deletion
NL174, NL175 
NL322, NL345
cps2E cps2F
Affected nucleotide(s) [amino acid]
NL119a T490C   [Cys164Arg]
NL257b ATCT
NL278a T259C   [Ser87Pro]
NL122a G52A     [Gly18Ser]
NL126 TCCG
NL132c G1199A [Arg400Lys]
NL143d G493T   [Asp165Tyr]
NL208e, NL219b, 
NL342b
TAAG
NL225 CCAAA
NL230 A
NL245 T
NL249 AGCA
NL266 A
NL295a T492G   [Cys164Trp]
NL328 AG
NL100a T696G   [Tyr232TERM]
NL146 T482A   [Leu162TERM]
NL240b C1189T [Gln397TERM]
38 
 
 
 
Figure 1.6. Transmission electron micrographs of S. suis. Ultrathin sections of 
coagglutination-negative isolates [(A) NL119, (B) NL257, and (C) NL278] and their 
complemented mutants [(D) NL119(pCps2F), (E) NL257(pCps2E), and (F) NL278(pCps2F)] 
were observed. Bar = 0.5 µm.  
A B C
D E F
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Figure 1.7. Putative inactivating mutations in the cps gene clusters of six unencapsulated isolates. Closed triangles indicate the positions of 
mutation. Open circles and rectangles indicate missense and frame shift mutations (caused by deletion), respectively. Black box represents 
deleted region. 
NL132
NL143
Insertion (9 bp)
NL174 & 
NL175
NL322
Deletion (50 bp)
Deletion (23 bp)
NL345
cps2A    cps2B cps2C cps2D    cps2E        cps2F      cps2G            cps2H         cps2I       cps2J     cps2K cps2L                 cps2N      cps2O             cps2P     cps2Q  cps2R   cps2S
cps2M 
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Chapter 2 
 
Putative lethal mutation in cps2 gene cluster of S. suis 
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2.1. Introduction 
CP of S. suis serotype 2 consists of glucose, galactose, N-acetyl glucosamine, 
rhamnose and sialic acid (Elliott & Tai, 1978; Smith et al., 1999a) and is considered to be 
synthesized by the Wzx/Wzy-dependent pathway. The biosynthesis of CP requires a group of 
cps genes clustered on the chromosome (Okura et al., 2013; Smith et al., 1999a; Smith et al., 
2000; Van Calsteren et al., 2010) (Figure 2.1). Among the genes in the cluster, cps2J is 
served as a molecular marker for serotypes 2 and 1/2, and thus, cps2J-positive strains are 
suspected to have capsule of serotype 2 or 1/2 (Smith et al., 1999c). However, the results 
from chapter 1 demonstrated that 34% of cps2J-positive S. suis isolates from porcine 
endocarditis have lost their capsules. Of 43 representative unencapsulated isolates analyzed 
by PCR analysis, 18 isolates had structural alterations in their cps gene clusters. Among 
them, 16 isolates had deletion or insertion within cps2A-2G and cps2P-2S (neuBCDA) 
regions of their cps gene clusters. The sequencing and complementation results of cps genes 
in the remaining 25 isolates demonstrated that more than 70% of the representative 
unencapsulated isolates have lost their capsules because of the mutations in cps2EF region. 
On the other hand, the mutation within the cps2IJ and cps2NO regions was rarely found in 
the unencapsulated endocarditis isolates analyzed in this study. Although a missense mutation 
was found in cps2N of NL345, this isolate also had a 23-bp deletion in cps2H (Table 1.7). 
Consequently, the mutations in the cps2IJ and cps2NO regions were proposed to affect the 
viability of S. suis, and mutations in these regions may be restricted only to the isolate 
carrying the additional mutation in other cps gene(s).  
The objective of the present chapter is to clarify whether the mutations in the cps2IJ 
and cps2NO regions are lethal for S. suis by the attempts to construct various cps deletion 
mutants.  
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2.2. Materials and methods 
2.2.1. Bacterial strains and growth conditions 
 Bacterial strains used in this chapter are listed in Table 2.1. S. suis strains were grown 
overnight in THB or THA (Difco Laboratories) at 37ºC in air plus 5 % CO2, unless otherwise 
indicated. E. coli strain was cultured in Luria-Bertani (Difco Laboratories) broth or agar at 
37ºC. When required, spectinomycin was added to the medium for E. coli at 50 µg/ml and for 
S. suis at 100 µg/ml. If necessary, 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside was 
added to the plates at 100 µg/ml.  
 
2.2.2. Plasmids, primers, and DNA techniques 
 Plasmids used for the experiments in this chapter are listed in Table 2.1. Genomic 
DNA of S. suis was extracted as described previously (Mogollon et al., 1990), and plasmid 
DNA of E. coli was purified as described in chapter 1. Primers listed in Table 2.2 and iProof 
HF Master mix (Bio-Rad Laboratories) were used for PCR to construct cps gene knockout 
vectors. The purification of PCR product, sequencing and analysis of the sequences were 
performed as described in chapter 1. Restriction enzymes and DNA-modifying enzymes were 
purchased from Takara Bio and used according to the manufacturer’s recommendations. The 
transformations of E. coli and S. suis were carried out following the procedures described in 
chapter 1. 
 
2.2.3. Construction of double crossover ∆cps2EF, ∆cps2IJ and ∆cps2NO mutants 
 The flanking regions of cps2EF, cps2IJ and cps2NO were amplified and fused by 
overlap-extension PCR (Warrens et al., 1997) using the primers listed in Table 2.2. The 
resultant PCR products were digested by PstI, EcoRI, and BamHI, respectively, and directly 
cloned into the respective sites of the temperature-sensitive S. suis-E. coli shuttle vector 
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pSET4s (Takamatsu et al., 2001a) to generate cps2EF, cps2IJ, and cps2NO knockout vectors. 
After introducing E. coli TOP10, the sequences of the knockout vectors were verified, and 
each knockout vector was subsequently introduced into S. suis strains 89/1591 and 
89/1591∆cps2EF by electroporation. Single crossover mutants were obtained by shifting the 
incubation temperature of the transformants to 37ºC in the presence of spectinomycin. The 
single crossover mutants obtained were then subcultured several times in THB at 28ºC in the 
absence of antibiotics, and dilutions of the subculture were plated on nonselective THA 
plates. The colonies that formed after overnight culture of the plates were screened for loss of 
vector-mediated spectinomycin resistance by inoculating these colonies to both THA–
spectinomycin and nonselective plates, and spectinomycin-susceptible colonies were selected 
as candidates, which may lose the target cps genes or returned to the wild-type as a result of 
double crossover recombination event. The deletion of target genes was confirmed by PCR, 
and if necessary, by sequencing. 
 
2.3. Results 
2.3.1. Generation of knockout mutants under wild-type and ∆cps2EF backgrounds 
For verification of the hypothesis that mutations in cps2IJ and cps2NO regions may 
affect the viability of S. suis and that the mutation in these regions may occur only in the 
presence of other mutation in cps gene(s), cps2IJ and cps2NO knockout vectors were 
introduced to strain 89/1591, generated single crossover mutants, in which the knockout 
vectors were integrated into the chromosome (Figure 2.2), and investigated whether double 
crossover ∆cps2IJ and ∆cps2NO mutants could be obtained from single crossover mutants. In 
addition, strain 89/1591∆cps2EF, which had lost its capsule due to the deletion of cps2EF, 
was also used as a parent strain to construct ∆cps2IJ and ∆cps2NO mutants. As illustrated in 
Figure 2.2, after the single crossover event between the introduced vector and host 
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chromosome, two types of single crossover mutants (pattern 1 and 2 mutants) were 
generated. However, when the cps2IJ knockout vector was used, only pattern 2 single 
crossover mutant was obtained from strain 89/1591. Therefore, only pattern 2 mutants were 
used to construct double crossover ∆cps2IJ mutants. 
The numbers of double crossover ∆cps2IJ and ∆cps2NO mutants obtained from 
strains 89/1591 and 89/1591∆cps2EF are summarized in Table 2.3. Although 2,556 and 16 
double crossover recombinants were obtained from strain 89/1591 transformed with cps2IJ 
and cps2NO knockout vectors, respectively, all the recombinants tested turned back to the 
parent genotype via double crossover recombination, and neither the ∆cps2IJ nor ∆cps2NO 
mutant was obtained. However, when 89/1591∆cps2EF was used as the host strain, ∆cps2IJ 
and ∆cps2NO mutants were obtained in 31.8% and 62.5%, respectively, of double crossover 
recombinants. 
 
2.4. Discussion 
Using molecular approaches, the results from the previous chapter showed that more 
than 70% of unencapsulated S. suis clinical isolates have lost their capsule because of 
inactivating mutations related to cps2E and cps2F, whereas no inactivating mutation was 
detected in cps2I, cps2J, or cps2O and only one missense mutation was found in cps2N 
among the unencapsulated endocarditis isolates analyzed in this study. Consistent with this 
result, experiments using recombination techniques suggested that the deletion of the cps2IJ 
and cps2NO regions was lethal for S. suis. S. suis CP is considered to be synthesized via 
Wzx/Wzy dependent pathway. In this pathway, as shown in Figure 2.1B, the initial 
glycosyltransferase catalyzes the transfer of the first sugar to a membrane-associated lipid 
carrier, and then further glycosyltransferases sequentially link additional sugars to form 
repeat units on the inner face of the cytoplasmic membrane. The Wzx flippase subsequently 
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transports the single repeat unit across the cytoplasmic membrane, and Wzy polymerase 
polymerizes the individual repeat units to generate lipid-linked CPs. Finally, mature CP is 
translocated to the peptidoglycan by the membrane protein complex encoded in the cps gene 
cluster (Bentley et al., 2006). According to the CP structure and proposed functions of cps 
genes of S. suis serotype 2, cps2E and cps2F are considered to encode the initial and second 
glycosyltransferases, respectively, of the Wzx/Wzy dependent pathway, whereas cps2J and 
cps2N are thought to be involved in side chain formation of the repeat unit (Figure 2.1B) 
(Van Calsteren et al., 2010). In addition, cps2I (wzy) and cps2O (wzx) were proposed to be 
responsible for capsular polysaccharide polymerase and flippase, respectively (Okura et al., 
2013; Smith et al., 1999a; Smith et al., 2000). Therefore, in S. suis, mutations of the genes 
involved in CP backbone formation seem to cause capsule loss, while loss of function of the 
genes responsible for the side chain formation, polymerase, and flippase are likely to be 
deleterious for S. suis. 
In Streptococcus pneumoniae serotype 2, the CP of which is synthesized by Wzx/Wzy 
dependent pathway, mutations in cps genes involved in the side chain formation, polymerase, 
and flippase were also suggested to be lethal (Xayarath & Yother, 2007). In the Wzx/Wzy 
dependent pathway, the undecaprenyl-phosphate (Und-P) is utilized as an essential lipid 
carrier molecule. The CP biosynthesis initiates on Und-P, and after transferring the repeat 
unit or polymer of CP to the final acceptor, Und-P is reversibly transported into the 
cytoplasmic membrane for recycling. In addition to initiation of the CP synthesis, Und-P is 
also used for the synthesis of peptidoglycan and teichoic acids in Gram-positive bacteria 
(Yother, 2011). Thus, lethality of mutations within these genes in S. pneumoniae is 
considered to result from sequestration of Und-P in the incomplete capsule synthesis 
pathway, reduction of available Und-P, and impairment of Und-P utilization in other crucial 
pathways (Xayarath & Yother, 2007; Yother, 2011). Moreover, the lethality of these 
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mutations is also possibly due to the accumulation of lipid-linked intermediates or single 
repeat units on the inner face of the cytoplasmic membrane, resulting in destabilization of the 
membrane (Xayarath & Yother, 2007; Yother, 2011). Because S. suis and S. pneumoniae 
utilize very similar CP biosynthesis pathways; therefore, a same explanation can reasonably 
describe the lethality in S. suis. Interestingly, deletions of genes involved in side chain 
formation, polymerase, and flippase occurred in the presence of additional mutations in S. 
pneumoniae, which were mostly located in the initial glycosyltransferase gene (Xayarath & 
Yother, 2007). Similar to this, although the deletion of cps2IJ and cps2NO regions did not 
occur in the parent S. suis strain, ∆cps2IJ and ∆cps2NO mutants could be obtained in the 
absence of the cps2EF region (Table 2.3), which indicated that mutations in the cps2EF 
region relieved the stress induced by lethal mutations in the cps2IJ and cps2NO regions. CP 
biosynthesis in the ∆cps2EF mutant is not supposed to start due to lack of the initial 
glycosyltransferase; therefore, even if the strain has mutations in the cps2IJ and cps2NO 
regions, free Und-P may be abundantly present on the cytoplasmic membrane; thus other 
crucial pathways may proceed smoothly. 
Because no transformant appeared from NL208 (chapter 1), complementation analysis 
of this isolate could not be accomplished. On the basis of the discussion described above, this 
failure was supposed to occur because of lethal cps mutations, i.e., NL208 possesses 
mutations somewhere in the cps2IJ and cps2NO regions in addition to the cps2E mutation, 
and the lethal effect of the mutations was invoked after supplying functional cps2E. Genes in 
the cps2IJ and cps2NO regions of NL208 were subsequently sequenced to investigate this 
hypothesis, and were shown to be intact; therefore, this difficulty may be due to other factors. 
Since NL208 exhibits adenine methylation activity (Figure 2.3), factors that protect it from 
foreign DNA, such as restriction-modification system and clustered regularly interspaced 
short palindromic repeats, may influence the transformation efficiency of the isolate. On the 
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other hand, in NL143, which had inactivating mutations in both cps2F and cps2K, although 
functional cps2F was successfully introduced into the isolate, the transformant showed very 
poor growth. It was also noted that the transformant introduced by functional cps2K was able 
to grow as well as the parent isolate (Figure 2.4). As illustrated in Figure 2.1B, cps2K was 
putatively involved in the side chain formation of the CPs, which implied that the mutation in 
cps2K may also be harmful to S. suis and that the mutation in cps2F was necessarily 
generated to relieve the detrimental effect from the cps2K mutation.  
According to the results from chapter 1, the mutations were detected in all 43 
representative isolates. Moreover, the mutations in cps regions were found to cause the loss 
of capsule or proposed to cause the death in S. suis. The lethal effect due to the mutations in 
genes involved in the side chain formation, polymerase, and flippase may highlight the 
alternative target for the development of novel therapeutic or preventive strategies for S. suis 
infection. 
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2.5. Summary 
 In the present chapter, the attempts to construct ∆cps2IJ and ∆cps2NO mutants have 
been made via double crossover recombination. Although 2,556 and 16 double crossover 
recombinants were obtained from strain 89/1591 transformed with cps2IJ and cps2NO 
knockout vectors, respectively, all the recombinants tested turned back to parent genotype. 
However, interestingly, the ∆cps2IJ and ∆cps2NO mutants can be obtained when 
89/1591∆cps2EF was used as a host strain. The results suggested that ∆cps2IJ and ∆cps2NO 
mutants can be derived only from the ∆cps2EF mutant, but not from its parent strain 
(89/1591), implying that the mutations in cps2IJ and cps2NO regions are lethal for S. suis, 
but the mutation in cps2EF region is effective in relieving the stress induced by the mutations 
in the two regions.  
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Table 2.1. Bacterial strains and plasmids used in this study. 
 
Strain or plasmid Relevant characteristics Source or reference 
S. suis strains 
  
89/1591 Wild-type strain isolated from a pig with septicemia and meningitis (Salasia et al., 1995) 
89/1591∆cps2EF 89/1591 derivative carrying a deletion in cps2E-cps2F This study 
89/1591∆cps2IJ 89/1591 derivative carrying a deletion in cps2I-cps2J This study 
89/1591∆cps2NO 89/1591 derivative carrying a deletion in cps2N-cps2O This study 
 
E. coli strain 
  
TOP10 Host for pSET4s derivatives Invitrogen 
 
Plasmids    
pSET4s Spc
r
, pUC ori, thermosensitive pG+host3 ori, lacZ′ (Takamatsu et al., 2001a) 
cps2EF knockout vector pSET4s carrying the flanking regions of cps2EF This study 
cps2IJ knockout vector pSET4s carrying the flanking regions of cps2IJ This study 
cps2NO knockout vector pSET4s carrying the flanking regions of cps2NO This study 
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Table 2.2. Primers used for construction of cps knockout vectors. 
 
Primer  Sequence (5'-3') Description PCR program
a
 
For construction of cps2EF knockout vector  
1-cps2EF GCGACTCTTCGTCGCTATTA For amplification of upstream region of cps2E. 98
o
C 2min - 98
o
C 10sec, 55
o
C 
10sec, 72
o
C 1min (30 cycles) - 
72
o
C 2min 2-cps2EF ACCACGTCTTGAAAGTGCGA For amplification of upstream region of cps2E. 
3-cps2EF GGAACGAACCCATCTTTACT For amplification of downstream region of cps2F.  98
o
C 2min - 98
o
C 10sec, 55
o
C 
10sec, 72
o
C 1min (30 cycles) - 
72
o
C 2min 4-cps2EF ACTTTGAGGGAGGTGTAGAC For amplification of downstream region of cps2F.  
5-cps2EF GATTCTGCAGCGAAGCTTATCGTCAAGGTG 
Used for amplification of upstream border of cps2E and 
generation of fused fragment to vector. PstI site is underlined. 98
o
C 2min - 98
o
C 10sec, 60
o
C 
10sec, 72
o
C 1min (30 cycles) - 
72
o
C 2min 
6-cps2EF TTCGCTCCTTCTTCCGCCAATTTCGTTTGG 
Used for amplification of upstream border of cps2E and 
generation of fused fragment to downstream-border fragment 
of cps2F.  
7-cps2EF CCAAACGAAATTGGCGGAAGAAGGAGCGAA 
Used for amplification of downstream border of cps2F and 
generation of fused fragment to upstream-border fragment of 
cps2E. 98
o
C 2min - 98
o
C 10sec, 60
o
C 
10sec, 72
o
C 1min (30 cycles) - 
72
o
C 2min 
8-cps2EF TCTCCTGCAGACCGAGCATCGGACTGA 
Used for amplification of downstream border of cps2F and 
generation of fused fragment to vector. PstI site is underlined. 
 
a
 All PCRs were performed by using iProof HF Master mix (Bio-Rad Laboratories). 
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Table 2.2. (continued) Primers used for construction of cps knockout vectors. 
 
Primer  Sequence (5'-3') Description PCR program
a
 
For construction of cps2IJ knockout vector  
1-cps2IJ GAGGCATATAATCAGTATCG For amplification of upstream region of cps2I. 98
o
C 2min - 98
o
C 10sec, 55
o
C 
10sec, 72
o
C 1min (30 cycles) - 
72
o
C 2min 2-cps2IJ TTGCTGACATATTCCGATAG For amplification of upstream region of cps2I. 
3-cps2IJ AAGAGGTGCGAGACTTAGGA For amplification of downstream region of cps2J.  98
o
C 2min - 98
o
C 10sec, 55
o
C 
10sec, 72
o
C 1min (30 cycles) - 
72
o
C 2min 4-cps2IJ AAGCTTCTTTTGCTGTTTGC For amplification of downstream region of cps2J.  
5-cps2IJ GAAAGAATTCGGCGCTCATTGAATCTGGCG 
Used for amplification of upstream border of cps2I and 
generation of fused fragment to vector. EcoRI site is underlined. 98
o
C 2min - 98
o
C 10sec, 60
o
C 
10sec, 72
o
C 1min (30 cycles) - 
72
o
C 2min 
6-cps2IJ AAGCGATTCATCTCCCACAGAAGCTTTGCC 
Used for amplification of upstream border of cps2I and 
generation of fused fragment to downstream-border fragment of 
cps2J.  
7-cps2IJ GGCAAAGCTTCTGTGGGAGATGAATCGCTT 
Used for amplification of downstream border of cps2J and 
generation of fused fragment to upstream-border fragment of 
cps2I. 98
o
C 2min - 98
o
C 10sec, 60
o
C 
10sec, 72
o
C 1min (30 cycles) - 
72
o
C 2min 
8-cps2IJ GGCAGAATTCGCGATGGTCAGTCATACTAG 
Used for amplification of downstream border of cps2J and 
generation of fused fragment to vector. EcoRI site is underlined. 
 
a
 All PCRs were performed by using iProof HF Master mix (Bio-Rad Laboratories). 
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Table 2.2. (continued) Primers used for construction of cps knockout vectors. 
 
Primer  Sequence (5'-3') Description PCR program
a
 
For construction of cps2NO knockout vector  
1- cps2NO GCTCAAGTTCAGCAGTGGTA For amplification of 5' flanking region of cps2N. 98
o
C 2min - 98
o
C 10sec, 55
o
C 
10sec, 72
o
C 1min (30 cycles) - 
72
o
C 2min 2- cps2NO AAGGGGGATACTGGGGTTTA For amplification of 5' flanking region of cps2N. 
3- cps2NO ACGTCCCAAATGAGAGGTGC For amplification of 3' flanking region of cps2O.  98
o
C 2min - 98
o
C 10sec, 55
o
C 
10sec, 72
o
C 1min (30 cycles) - 
72
o
C 2min 4- cps2NO ATCCTACGCTTGTCCGCTTC For amplification of 3' flanking region of cps2O.  
5- cps2NO CATCGGATCCTTCATTTGTCCTGTGGCTAC 
Used for amplification of 5' flanking region of cps2N and 
generation of fused fragment to vector. BamHI site is 
underlined. 98
o
C 2min - 98
o
C 10sec, 60
o
C 
10sec, 72
o
C 1min (30 cycles) - 
72
o
C 2min 
6- cps2NO GGCAGTGATGGTCAAGGCATCTGCTAATCT 
Used for amplification of 5' flanking region of cps2N and 
generation of fused fragment to 3' flanking fragment of cps2O. 
7- cps2NO AGATTAGCAGATGCCTTGACCATCACTGCC 
Used for amplification of 3' flanking region of cps2O and 
generation of fused fragment to 5' flanking fragment of cps2N. 98
o
C 2min - 98
o
C 10sec, 60
o
C 
10sec, 72
o
C 1min (30 cycles) - 
72
o
C 2min 
8- cps2NO TGGCGGATCCCTGTGCTAATCAAGAAGTCC 
Used for amplification of 3' flanking region of cps2O and 
generation of fused fragment to vector. BamHI site is 
underlined. 
 
a
 All PCRs were performed by using iProof HF Master mix (Bio-Rad Laboratories). 
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Table 2.3. Numbers of ∆cps2IJ and ∆cps2NO double crossover mutants derived from the 
89/1591 and 89/1591∆cps2EF strains. 
 
Host strain Target genes 
No. of ∆cps2IJ or ∆cps2NO mutants/ 
double crossover recombinants (%) 
89/1591 cps2IJ 0/300
a,b
 (0%) 
89/1591∆cps2EF cps2IJ 7/22a (31.8%) 
89/1591 cps2NO 0/16
c
 (0%) 
89/1591∆cps2EF cps2NO 35/56c (62.5%) 
 
a
 Double crossover recombinants were obtained by screening 3000 colonies derived from 
pattern 2 single crossover mutant (Figure 2.2A).  
b
 Of the 2,556 double crossover recombinants obtained, 300 colonies were representatively 
examined by PCR. 
c
 Double crossover recombinants were obtained by screening 2000 colonies from pattern 1 
and 2000 colonies from pattern 2 single crossover mutants (Figure 2.2B). 
 5
4
 
 
  
cps2A    cps2B       cps2D   cps2E       cps2F    cps2G       cps2H       cps2I     cps2J  cps2K  cps2L           cps2N    cps2O       cps2P   cps2Q  cps2R  cps2S
cps2M cps2T
cps2U        cps2V
cps2C 
Cytoplasmic membrane
Peptidoglycan
P
P
P
P
P
P
P
Cps2E
Cps2F
Cps2H Cps2J
Cps2K
Cps2G
Cps2N
P
P
P
P
Cps2O
P
P
Cps2I
n
Wzd/Wze complex
(CpsB/CpsC)
(Wzx flippase) (Wzy polymerase)
P P Lipid carrier
Glucose
Rhamnose
Galactose
N-acetyl glucosamine
N-acetyl neuraminic acid 
(sialic acid)
Key:
A 
B 
 5
5
 
Figure 2.1. Genetic organization of S. suis serotype 2 cps gene cluster and tentative serotype 2 CP biosynthesis model. (A) The genetic 
organization of serotype 2 cps gene cluster (Okura et al., 2013). Gray arrows represent genes putatively involved in capsule synthesis. Open 
arrows indicate genes with unknown function. Black arrows indicate putative transposase or integrase. (B) The hypothetical model for 
biosynthesis of S. suis serotype 2 CPs was illustrated on the basis of the Wzx/Wzy dependent pathway for the biosynthesis of pneumococcal CP 
proposed by Bentley et al. (2006), CP structure of S. suis serotype 2, and function of glycosyltransferases proposed by Van Calsteren et al. 
(2010). The putative glucosyl-1-phosphate transferase encoded by cps2E transfers the glucose residue to the lipid carrier and then more 
glycosyltransferases link the additional sugars to form repeat unit. The synthesized repeat unit is transported across the cytoplasmic membrane 
by the action of flippase encoded by cps2O and each repeat unit is polymerized by Wzy polymerase encoded by cps2I. Subsequently, mature CP 
is translocated to the peptidoglycan by the Wzd/Wze protein complex putatively encoded by cps2B and cps2C. The latest cps gene names 
reassigned by Okura et al. (2013) were used in this figure.  
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Figure 2.2. Patterns of single crossover and double crossover recombination possibly 
occurred in the course of construction of the ∆cps2IJ and ∆cps2NO mutants. Open arrow 
heads represent the positions of primers used for the construction of deletion mutants. The 
expected size of PCR product was indicated. (A) Patterns of single and double crossover 
recombination in the construction of ∆cps2IJ mutant. (B) Patterns of single and double 
crossover recombination in the construction of ∆cps2NO mutant. 
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Figure 2.3. Methylation of 5′-GATC-3′ sequence in the DNA of unencapsulated isolate 
NL208. DNA from NL208 was treated with two complementary restriction endonucleases 
and analyzed by agarose gel electrophoresis. The result showed that DNA of NL208 was 
digested by DpnI (specific for methylated sequence) but not by MboI (specific for 
unmethylated sequence), indicating methylation of adenine at its 5′-GATC-3′ sequence.      
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Figure 2.4. Growth of the NL143 transformants on THA-spectinomycin plates. (A) NL143 
transformant introduced by pCps2F showed very poor growth. (B) NL143 transformant 
introduced by pCps2K was able to grow well. 
   
A 
B 
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Chapter 3 
 
The biological significance of the unencapsulation in the 
pathogenesis of infective endocarditis 
61 
 
3.1. Introduction 
Bacterial CPs generally serve as a physical barrier to protect bacterial cells from the 
host immune system. The CPs of S. suis have been found to destabilize the lipid 
microdomains of macrophages and prevent pathogen patterns from being recognized (Houde 
et al., 2012). Encapsulated S. suis has also been proposed to attach to phagocytes and 
subsequently disseminate through blood circulation leading to septicemia (Segura & 
Gottschalk, 2002). Moreover, encapsulated S. suis, particularly serotype 2, can be viable in 
dendritic cells, which may enable S. suis to be released and then spread in the body to cause 
an invasive disease (Meijerink et al., 2012). Although capsule has so far been known as an 
essential virulence factor, the capsule loss in a notable number of S. suis isolates from pigs 
with endocarditis was demonstrated in the previous chapter. According to the results from 
PCR, sequencing, and complementation analyses, the causes of unencapsulation in all 43 
representative isolates were elucidated. However, the phenotypic characteristics which 
potentially facilitate the pathogenesis of infective endocarditis in these isolates remained 
unknown.  
Adherence of bacteria in the bloodstream to platelets on the damaged endocardial 
surface is thought to be an important mechanism for the initial colonization of cardiac valves 
(Sullam et al., 1996). In association with prior injury or disease of the heart valves, the 
endothelial or exposed connective tissue surface becomes coated with platelets and fibrin. 
Subsequently, the circulating microorganisms adhere to and colonize the platelet vegetation, 
and the colonies are typically encased in more platelets and fibrin, forming the primary 
infectious lesion or septic vegetation (Herzberg, 1996). As well as the adherence ability, the 
biofilm plays a key role contributing to the formation of a primary infection lesion on cardiac 
valve (Parsek & Singh, 2003) and biofilm formation by the bacterial pathogens is also 
considered to be important for them to persist in host and to protect themselves from host 
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immune system or to increase the resistance to antibiotics (Donlan & Costerton, 2002). Thus, 
the isolation of unencapsulated isolates from porcine endocarditis case may result from the 
advantageous property of the isolates to form septic vegetations.  
The aim of this chapter is to examine the biological significance of unencapsulation in 
the pathogenesis of endocarditis including bacterial adherence to platelets and ability to form 
biofilm. Furthermore, the ability of encapsulated cells to adhere to the biofilm produced by 
unencapsulated isolates is investigated and the result suggests further advantage of 
unencapsulation in the establishment of S. suis infection. 
 
3.2. Materials and methods 
3.2.1. Bacterial strains, plasmids and growth conditions 
 Four unencapsulated S. suis isolates and three of their complemented mutants 
obtained from chapter 1 were selected for the experiments in this chapter. The bacteria and 
plasmids used in this study are listed in Table 3.1. S. suis isolates, strains, and mutants were 
grown overnight in THB or THA (Difco Laboratories) at 37ºC in air plus 5 % CO2, unless 
otherwise indicated. E.coli strains were cultured in Luria-Bertani (Difco Laboratories) broth 
or agar at 37ºC. When required, spectinomycin was added to the medium for E. coli at 50 
µg/ml and for S. suis at 100 µg/ml.  If necessary, 5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside was added to the plates at 100 µg/ml.  
  
3.2.2. Bacterial adherence to porcine and human platelets 
The ability of encapsulated and unencapsulated strains to adhere to porcine and 
human platelets was evaluated according to a procedure described elsewhere (Hoshinoo et 
al., 2009) with appropriate modifications. For preparation of the inocula, S. suis strains were 
cultured in THB or THB with spectinomycin (for strain CPS2B) until the absorbance at 600 
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nm reached 0.8. The cultured bacteria were washed twice with DPBS, sonicated in DPBS for 
30 sec to disperse the bacterial cells, and then diluted with DPBS to approximately 2 × 10
9
 
CFU/ml. The bacterial suspensions were additionally diluted in triplicate and each dilution 
was plated twice onto THA to examine the exact concentration of the inocula each time.     
Porcine venous blood was freshly obtained from healthy adult pigs kept in National 
Institute of Animal Health (Ibaraki, Japan), and the platelets were prepared by centrifuging 
the blood at 100 g for 15 min and collecting the upper layer. Human platelets donated for 
transfusion were obtained from the Japan Red Cross Society. The collected platelets were 
washed twice with platelet wash buffer (0.14 M NaCl, 20 mM HEPES, 1 mM EDTA [pH 
6.6] containing prostaglandin I2 1 µg/ml for first wash), fixed with 0.8 % formalin in DPBS, 
and immobilized in 8-well culture slides (BD Falcon glass; Becton Dickinson) coated with 
0.01 % poly-L-lysine solution at approximately 1 × 10
8 
platelets/well. The wells were treated 
with 1 × blocking reagent (Roche Applied Science, Mannheim, Germany) for 1 h with gentle 
rocking at room temperature to minimize nonspecific adherence. After removal of the 
blocking reagent by aspiration, 500 µl of each bacterial suspension was inoculated into the 
wells to give multiplicity of infection at approximately 10. After incubation with gentle 
shaking for 2 h at room temperature, platelets were washed 4 times with DPBS to remove the 
unattached bacteria, fixed with pre-chilled methanol, and stained with 5 % Giemsa solution. 
The numbers of bacterial cells attached to 100 platelets were determined by light microscopy. 
In each strain or isolate, the assay was repeated six times using porcine platelets from two 
different pigs and twelve times using human platelets of three different lots.  
 
3.2.3. Construction of double crossover ∆cps2A-2S mutant 
 Double crossover ∆cps2A-2S mutant derived from S. suis strain P1/7 was constructed 
to examine the ability to form biofilm. The flanking regions of cps2A-2S genes were 
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amplified by iProof HF Master mix (Bio-Rad Laboratories) in accordance with the 
manufacturer’s instructions using primers listed in Table 3.2 and fused by overlap-extension 
PCR as described previously (Warrens et al., 1997). The resulting PCR products were cloned 
into pCR2.1 (Invitrogen, San diego, California, U.S.A.), digested with BamHI and recloned 
into BamHI site of temperature-sensitive S. suis - E. coli shuttle vector pSET4s (Takamatsu et 
al., 2001a) to generate cps2AS knockout vector. The double crossover ∆cps2A-2S mutant was 
constructed following the procedures described in chapter 2 and its sequence was 
subsequently verified.  
 
3.2.4. Biofilm formation assay 
The biofilm produced by S. suis strain P1/7 was compared with that from its isogenic 
unencapsulated ∆cps2A-2S mutant. The production of biofilm was examined as described 
elsewhere (Grenier et al., 2009) with slight modifications. The overnight cultures of strain 
P1/7 and its ∆cps2A-2S mutant in THB were inoculated to 200 µl of biofilm broth containing 
(w/v) 0.5% glucose, 2% peptone (proteose peptone no.3), 0.3% K2HPO4, 0.2% KH2PO4, 
0.01% MgSO4 · 7H2O, 0.002% MnSO4 · 6H2O and 0.5% NaCl in sterile 96-well flat bottom 
plate and incubated at 37ﾟC for 18-24 h. The medium and free-floating bacteria were gently 
removed and the wells were washed three times with 200 µl of PBS. After 10 min staining 
with 100 µl of 0.04% crystal violet, the wells were washed three times with 200 µl of PBS 
and dried for 2 h at 37 ºC. Then, 100 µl of 95% (v/v) ethanol was added to each well and the 
plate was shaken for 10 min to release the dye. The biofilms were evaluated by measuring of 
the absorbance at 570 nm (A570). The assay was performed in triplicate and repeated for five 
times. 
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3.2.5. Adherence of encapsulated cells onto the biofilm produced by unencapsulated 
isolates 
 The biofilm of unencapsulated S. suis isolates (NL119, NL122 and NL342) was 
produced by inoculating the isolates into 200 µl of biofilm broth in flat-bottom 96-well plates 
and incubating the plates at 37ﾟC for 18-24 h. Some wells were incubated with the biofilm 
broth only, as negative controls. 
For the inocula preparation, the encapsulated complemented mutants of NL119, 
NL122 and NL342 carrying spectinomycin-resistant gene on the complementation vectors 
were cultured on THA-spectinomycin plates. After overnight incubation, the encapsulated 
cells were harvested, washed once with THB, and resuspended in THB. The bacterial 
suspension was diluted with THB until the absorbance at 600 nm reached 0.4, sonicated for 
30 sec to disperse the bacterial cells, and then diluted with THB to approximately 1 × 10
6
 
CFU/ml. The bacterial suspensions were additionally diluted in triplicate and each dilution 
was plated twice onto THA-spectinomycin plates to examine the exact concentration of the 
inocula each time.  
Both biofilm and control wells were gently washed with 100 µl THB followed by 100 
µl of each inoculum being inoculated. After incubation with gentle shaking for 2.5 h at room 
temperature, all wells were washed twice with 100 µl DPBS to remove the unattached cells. 
Then, 100 µl of fresh THB was added, and the attached cells were retrieved by scraping the 
bottom of each well and pipetting up and down. The number of attached encapsulated cells 
was determined by making three independent dilutions and plating 10 µl of each dilution 
twice on THA-spectinomycin plates. The percentage of encapsulated cells attached to the 
biofilm was compared with that of the control well. The assay was repeated 5 times in each 
isolate and the utmost deviate data was excluded from the calculation. 
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3.2.6. Statistical analysis 
The results of quantification in each experiment were expressed as means ± standard 
deviation. The significant differences between the results from encapsulated strain and 
unencapsulated isolate, strain or negative control were statistically analyzed by the Student’s 
t-test at 95% confidence interval (P < 0.05).  
 
3.3. Results 
3.3.1. The ability of S. suis to adhere to porcine and human platelets 
The ability of encapsulated strain P1/7 to adhere to porcine platelets was compared 
with unencapsulated endocarditis isolate NL194. As shown in Figures 3.1 and 3.2, the 
average number of attached bacteria per porcine platelet of NL194 (2.55 ± 0.3) was 
significantly higher than that of P1/7 (0.21 ± 0.07) (P < 0.05). In addition, the encapsulated 
serotype 2 strain 89/1591 and its isogenic unencapsulated mutant CPS2B were analyzed to 
evaluate the effect of unencapsulation. CPS2B also adhered to porcine platelets at greater 
degree than 89/1591 (average no. of attached bacteria/porcine platelet: 2.02 ± 0.2 for CPS2B 
vs, 0.44 ± 0.15 for 89/1591; P < 0.05) (Figures 3.1 and 3.2). Similar results were obtained 
when human platelets were used (average no. of attached bacteria/human platelet: 2.16 ± 0.22 
for NL194 vs, 0.53 ± 0.38 for P1/7; P < 0.05 and 2.2 ± 0.37 for CPS2B vs, 0.92 ± 0.7 for 
89/1591; P < 0.05) (Figure 3.3).  
 
3.3.2. Biofilm formation ability of unencapsulated cells 
 The amount of biofilm produced by encapsulated strain P1/7 was compared to that of 
its isogenic unencapsulated ∆cps2A-2S mutant. As shown in Figure 3.4, the amount of 
biofilm produced by unencapsulated ∆cps2A-2S mutant (biofilm quantification at A570: 0.82 ± 
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0.1) was significantly greater than that of its parent strain P1/7 (biofilm quantification at A570: 
0.24 ± 0.01), at 95% confidence interval (P < 0.05).  
 
3.3.3. Effect of biofilm formation by unencapsulated isolates on the adherence of 
encapsulated cells to surfaces 
For demonstrating further advantage of the unencapsulation events, in particular 
benefit of unencapsulation in a subpopulation to the entire S. suis population, the ability of 
encapsulated S. suis cells to adhere to plastic wells coated with and without biofilms of 
unencapsulated S. suis was compared. Three isolates (NL119, NL122, and NL342) and their 
cps2E- or cps2F-complemented mutants were used as unencapsulated and encapsulated S. 
suis, respectively. 
 As shown in Figure 3.5, when NL119 and NL122 were investigated, the ability of 
encapsulated cells to adhere to biofilms was significantly higher than that to non-coated 
control wells (% attached encapsulated cells in NL119: 1.36 ± 0.36 for wells with biofilm vs, 
0.98 ± 0.28 for control wells; P < 0.05 and in NL122: 2.53 ± 0.32 for wells with biofilm vs, 
1.18 ± 0.46 for control wells; P < 0.05). Although significant differences were not 
demonstrated due to the unstable results, a similar result was also observed in NL342 (% 
attached encapsulated cells: 3.28 ± 1.32 for well with biofilm vs, 2.24 ± 1.04 for control 
well). It was noticeable that NL119 produced less amount of biofilm than NL122 and NL342. 
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3.4. Discussion 
Although the advantage of the bacterial capsule has been described so far, Salasia et 
al. (1995) and Benga et al. (2005 & 2004) reported that the isogenic unencapsulated mutants 
showed increased adherence to various types of cells, including porcine endothelial cells and 
human epithelial cells, when compared with the parent serotype 2 strains. Esgleas et al. 
(2005) also demonstrated that an unencapsulated mutant bound to extracellular matrix 
proteins to a higher degree than its parental encapsulated serotype 2 strain. In agreement with 
the previous studies, the results in this chapter demonstrated that both unencapsulated isolate 
from endocarditis and the isogenic unencapsulated mutant (CPS2B) had a higher degree of 
adherence to porcine platelets than the encapsulated strains. Moreover, increased adherence 
of the unencapsulated isolates to human platelets was also observed. Although human cases 
of endocarditis caused by unencapsulated S. suis have not yet been reported, an 
unencapsulated isolate from the blood of an endocarditis patient has previously been reported 
in GBS (Sellin et al., 1992). Therefore, these results may suggest the potential of 
unencapsulated S. suis to cause infective endocarditis in humans. 
For elimination of the variation of genetic background and for exact examination of 
the effect of the unencapsulation on the biofilm formation, an encapsulated S. suis strain P1/7 
and its ∆cps2A-2S mutant were used as the representatives in the biofilm formation assay. 
Because of the deletion of all cps genes putatively involved in CP synthesis, this mutant 
completely lost its capsule and all components for capsule synthesis. Moreover, the ∆cps2A-
2S mutant will be useful for the other further studies including the mutagenesis to identify 
specific genes or proteins involving in the adherence ability. In accordance with the study by 
Tanabe et al. (2010), a capsular-deficient S. suis mutant acquired the capacity to form a thick 
biofilm, which was not observed in the parent strain. Although the exact role of biofilm 
formation in S. suis infections is unclear, such a property may allow bacteria to become 
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persistent colonizers and to resist clearance by the host immune system. The biofilm-positive 
phenotype of unencapsulated mutants therefore may give them further advantage to form 
cardiac vegetations in swine.  
As shown in chapters 1 and 2, mutations in the cps gene cluster may result in either 
loss of capsule or death, depending on the position of the mutations. In addition, loss of 
capsule is known to make the bacterial cells susceptible to phagocytosis by host immune 
cells; therefore mutations in cps genes seem to be risky for individual cells. However, as 
demonstrated in this study, unencapsulation due to cps mutations was actually proved to be 
beneficial to individual cells in the course of infection by enhancing the ability of the 
bacterial cells to adhere to host cells as well as to form thick biofilms. Furthermore, the 
biofilms produced by the unencapsulated cells were demonstrated to help the encapsulated 
cells to adhere the surfaces. Of note, NL119 produced less amount of biofilm than NL122 
and NL342; therefore, this may have caused the relatively lower number of attached 
encapsulated NL119 mutants to the biofilm compared to the other two.  
These results suggest that unencapsulation in S. suis can bring an advantage not only 
to the individual cells but also to the entire population by increasing the adhesiveness of the 
encapsulated population using the biofilms produced by unencapsulated subpopulation. 
Therefore, in the host, mutations that occur in cps genes may generate unencapsulated 
subpopulations in the infected S. suis population, and such unencapsulated subpopulations 
may contribute to the establishment of the infection by colonizing on the host surfaces using 
its increased adherence, forming thick biofilms, and working as a scaffold for further 
colonization of the remaining encapsulated population.  
As shown in the previous chapters, 66% of the endocarditis isolates analyzed in this 
study were found to have capsule, while 34% were unencapsulated. It is possible that both 
encapsulated and unencapsulated cells may be present in the same or different steps of the 
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course of infection; however, both encapsulated and unencapsulated cells have not hitherto be 
retrieved from the same clinical sample. This is presumably due to a big gap between the 
numbers of each cell type. Therefore, the additional experiments, e.g. inoculating the 
experimental animal with both encapsulated and unencapsulated cells and investigating 
whether both types of cells can be recovered from the infected site in the same animal, should 
be further performed to verify this hypothesis.      
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3.5. Summary 
The binding ability of bacteria to platelets, a major virulence determinant in the 
pathogenesis of infective endocarditis was analyzed using representative isolate and strains 
including strain 89/1591, and its isogenic unencapsulated mutant (89/1591CPS2B). The 
results showed that the platelet-binding ability of unencapsulated isolate and mutant was 
significantly greater than those of encapsulated strains. Moreover, the unencapsulated cells 
can enhance the ability to form biofilm and increase the adhesiveness of the strain by 
increasing the number of the attached encapsulated cells to the biofilm produced at the 
surface by unencapsulated population. Although the capsule is thought to be an important 
virulence factor for S. suis, these results suggest that the loss of capsular expression is also 
beneficial for S. suis to cause infective endocarditis in swine.  
  
 7
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Table 3.1. Bacterial isolates, strains, mutants, and plasmids used for the experiments in this chapter. 
Isolate, strain, mutant or 
plasmid 
Relevant characteristics Source or reference 
S. suis isolates, strains, and mutants 
NL119 Unencapsulated isolate from pigs with endocarditis This study 
NL122 Unencapsulated isolate from pigs with endocarditis This study 
NL194 Unencapsulated isolate from pigs with endocarditis This study 
NL342 Unencapsulated isolate from pigs with endocarditis This study 
NL119(pCps2F) NL119 carrying pCps2F This study 
NL122(pCps2F) NL122 carrying pCps2F This study 
NL342(pCps2E) NL342 carrying pCps2E This study 
P1/7 Wild-type strain isolated from a pig with meningitis (Slater et al., 2003) 
89/1591 Wild-type strain isolated from a pig with septicemia and meningitis (Salasia et al., 1995) 
89/1591CPS2B 89/1591 derivative carrying an insertionally inactivated cps2B (cps2B::pSET4s) (Okura et al., 2011) 
P1/7∆cps2A-2S P1/7 derivative carrying a deletion in cps2A-2S genes This study 
E. coli strain 
TOP10 Host for pCR2.1 and pSET4s derivatives Invitrogen 
Plasmids  
pCR2.1 Ap
r
, Km
r
, pUC ori, f1 ori, lacZα Invitrogen 
pSET4s Spc
r
, pUC ori, thermosensitive pG+host3 ori, lacZ′ (Takamatsu et al., 2001a) 
cps2AS knockout vector pSET4s carrying flanking regions of cps2A-2S genes This study 
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Table 3.2. Primers used for the construction of cps2AS knockout vector. 
Primer Sequence (5'-3') Description PCR program
a
 
1-cpsKO GTTCCTCTATTCCAGTCAAA For amplification of upstream region of cps2A. 98
o
C 2min - 98
o
C 10sec, 55
o
C 10sec, 
72
o
C 1min (30 cycles) - 72
o
C 2min 
2-cpsKO ACGACTTACTTCGTCCGCTT For amplification of upstream region of cps2A. 
3- cpsKO GATGCTAGCCTTGAGAATTG For amplification of 3' flanking region of cps2S. 98
o
C 2min - 98
o
C 10sec, 55
o
C 10sec, 
72
o
C 1min (30 cycles) - 72
o
C 2min 
4- cpsKO GTCTACCCACTACAGTTGAC For amplification of 3' flanking region of cps2S. 
5- cpsKO GCCCAAGCTTATAGACTATGTTACTAGCTA 
Used for amplification of 5' flanking region of cps2A and 
generation of fused fragment to vector. HindIII site is 
underlined. 98
o
C 2min - 98
o
C 10sec, 62
o
C 10sec, 
72
o
C 1min (30 cycles) - 72
o
C 2min 
6- cpsKO GACAGCTCTCCTCATACCTATAACGCATCC 
Used for amplification of 5' flanking region of cps2A and 
generation of fused fragment to 3' flanking fragment of 
cps2S. 
7- cpsKO GGATGCGTTATAGGTATGAGGAGAGCTGTC 
Used for amplification of 3' flanking region of cps2S and 
generation of fused fragment to 5' flanking fragment of 
cps2A. 98
o
C 2min - 98
o
C 10sec, 62
o
C 10sec, 
72
o
C 1min (30 cycles) - 72
o
C 2min 
8- cpsKO ATTGAAGCTTACTAGTTTTTGCCCAGCCTC 
Used for amplification of 3' flanking region of cps2S and 
generation of fused fragment to vector. HindIII site is 
underlined. 
 
a
 All PCRs were performed by using iProof HF Master mix (Bio-Rad Laboratories). 
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Figure 3.1. Adherence of encapsulated and unencapsulated S. suis strains, an isolate, and a 
mutant to porcine platelets. Bacterial cells and platelets were stained with 5 % Giemsa 
solution and observed under light microscopy: (A) encapsulated serotype 2 strain P1/7; (B) 
unencapsulated endocarditis isolate NL194; (C) encapsulated serotype 2 strain 89/1591; (D) 
isogenic unencapsulated mutant of strain 89/1591 (CPS2B). Black and open arrowheads 
indicate platelets and bacterial cells, respectively. Magnification, 1000x. 
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Figure 3.2. The ability of S. suis strains, an isolate, and a mutant to adhere to porcine 
platelets. Asterisks indicate significant differences: P < 0.05.   
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Figure 3.3. The ability of S. suis strains, an isolate, and a mutant to adhere to human 
platelets. Asterisks indicate significant differences: P < 0.05.   
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Figure 3.4. The biofilm formation ability of S. suis strain P1/7 compared with that of its 
isogenic unencapsulated ∆cps2A-2S mutant. Asterisk indicates significant difference: P < 
0.05. 
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Figure 3.5. The adherence of encapsulated cells from complemented mutants to the biofilm 
produced by their isogenic unencapsulated isolates. The percentage of encapsulated cells 
attached to biofilm was compared with the negative control (without biofilm formed by 
unencapsulated cells). Asterisks indicate significant differences: P < 0.05. 
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General discussion and conclusion 
  
80 
 
 S. suis, particularly serotype 2, is a pathogen of both pigs and humans associated with 
a wide range of diseases, including meningitis, septicemia and endocarditis. CP of serotype 2 
consists of glucose, galactose, N-acetyl glucosamine, rhamnose, and sialic acid and its 
biosynthesis requires a group of genes in cps gene cluster. Among S. suis cps genes, cps2J 
exists only in strains of serotypes 2 and 1/2; therefore, cps2J-positive strains are suspected to 
have capsules of serotype 2 or 1/2. However, it was noticed that, unlike isolates from other 
symptoms, many cps2J-positive isolates from porcine endocarditis were not indeed 
agglutinated by either anti-serotype 1 or anti-serotype 2 sera, suggesting frequent loss of 
capsular expression in porcine endocarditis isolates.  
The objectives of this study were to verify the loss of capsule in cps2J-positive S. suis 
isolates from pigs with endocarditis, to elucidate the unencapsulation mechanism, and to 
examine the biological significance of the loss of capsule in the pathogenesis of infective 
endocarditis. 
 In chapter 1, a total of 288 cps2J-positive isolates from diseased pigs were analyzed. 
By coagglutination tests and TEM, all 32 isolates from pigs with meningitis were confirmed 
to be encapsulated, while 86 (34%) of 256 isolates from pigs with endocarditis were 
identified as unencapsulated isolates. Forty-three representative unencapsulated isolates were 
subsequently selected at random to verify mutations in the genes of cps gene cluster by PCR 
analysis. Among them, 18 isolates were demonstrated to have insertion or deletion(s) in their 
cps gene clusters. Subsequently, the cps gene clusters of the remaining 25 isolates were 
analyzed by sequencing and complementation. The results demonstrated that most of the 
remaining isolates had nucleotide alterations of a single or a few base pairs in the cps2E-2F 
region, causing frameshift, missense or nonsense mutation(s) of the genes. These results 
indicated that at least 32 of 43 representative unencapsulated isolates have lost their CPs due 
to the mutations involving two glycosyltransferase genes (cps2E and cps2F). On the contrary, 
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no inactivating mutation was detected in cps2I, cps2J, and cps2O and only one missense 
mutation was found in cps2N among all unencapsulated endocarditis isolates analyzed, 
implying that mutations in these regions may affect the viability of S. suis.  
In chapter 2, the attempts to construct various cps deletion mutants have been done 
via double crossover recombination. The results suggested that ∆cps2IJ and ∆cps2NO 
mutants can be derived only from the ∆cps2EF mutant, but not from its parent strain 
(89/1591), implying that mutations in cps2I-2J and cps2N-2O regions are lethal for S. suis. 
However, additional mutations in cps2E-2F can relieve the fatal effect induced by the 
mutations in these two regions.  
As well as the majority of S. pneumoniae serotypes, S. suis CP is considered to be 
synthesized via Wzx/Wzy dependent pathway. According to the CP structure and proposed 
functions of cps genes of S. suis serotype 2, cps2E and cps2F are considered to encode the 
initial and second glycosyltransferases, respectively, of the Wzx/Wzy-dependent pathway, 
whereas cps2J and cps2N are thought to be involved in side chain formation of the repeat 
unit. In addition, cps2I (wzy) and cps2O (wzx) were proposed to be responsible for capsular 
polysaccharide polymerase and flippase, respectively. Therefore, in S. suis isolates from 
porcine endocarditis, mutations of the genes involved in CP backbone formation seem to 
cause their capsule loss, while loss of function of the genes responsible for the side chain 
formation, polymerase, and flippase are likely to be harmful for S. suis. 
Since CP has so far been known as an important virulence factor for S. suis, the 
capsule loss of many porcine endocarditis isolates found in this study may suggest some role 
of unencapsulation in the pathogenesis of endocarditis. Therefore, in chapter 3, the biological 
significance of unencapsulation to the pathogenesis of infective endocarditis was 
investigated. The examination of bacterial binding ability to porcine platelets, a major 
virulence determinant in the pathogenesis of infective endocarditis, using encapsulated strain 
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P1/7 and a representative unencapsulated endocarditis isolate (NL194) showed that the 
platelet-binding ability of unencapsulated isolate was significantly higher than that of 
encapsulated strain. In addition, the unencapsulated mutant 89/1591CPS2B adhered to the 
platelets greater degree than its encapsulated parent strain 89/1591 (P < 0.05). Similar results 
were also obtained when human platelets were used, suggesting that the frequent isolation of 
unencapsulated isolates from porcine endocarditis may result from advantageous property of 
individual unencapsulated cells to cause infective endocarditis. 
The biofilm formation ability of the unencapsulated ∆cps2A-2S mutant was 
additionally demonstrated to be significantly higher degree than its encapsulated parent strain 
P1/7. Although encapsulated S. suis strains showed low degree of ability to adhere to host 
cells, adherence assays using encapsulated and unencapsulated cells demonstrated that the 
biofilm produced by unencapsulated cells promotes the adherence of encapsulated cells to 
surfaces. Therefore, in the host, unencapsulated subpopulation generated due to cps mutations 
may contribute to the establishment of the infection by increasing adherence ability to 
colonize on the host surfaces, along with forming thick biofilm to promote the adhesiveness 
of the entire population. Although mutations in some cps genes were found to be risky for 
individual cells, these results suggest that loss of capsule production is beneficial for S. suis 
to cause infective endocarditis.  
The phenotypic variation derived from genomic variations within bacterial population 
is generally proposed to be beneficial for the survival of bacteria in stress conditions or 
environmental changes (Ryall et al., 2012). Genetic heterogeneity may occur during infection 
in an infected bacterial population, which contributes to its fitness and prolonged existence in 
the host; therefore, mutations, a major mechanism contributing to the genetic diversity of 
bacterial populations, may play a crucial role in the course of infections.   
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As suggested in this study, cps mutations may result in the death of individual cells; 
however, even dead cells are beneficial to the remaining population because they provide 
public goods for the survivors. By releasing pneumolysin through cell lysis, S. pneumoniae 
can enhance the colonization of its population in the host (Hirst et al., 2004). Extracellular 
DNA, an important structural component of the Staphylococcus aureus biofilm, is also 
released via cell lysis (Rice et al., 2007). Furthermore, under the condition of amino acid 
depletion, E. coli can trigger programmed cell death, which is proposed to provide nutrients 
to the remaining cells (Aizenman et al., 1996). Although the advantages obtained from cell 
death in the S. suis subpopulation has not yet been clarified, the results from this study may 
initially expand the view of altruistic death in the S. suis population.  
In conclusion, this study demonstrated that approximately one third of the isolates 
from porcine endocarditis lost the ability to produce capsules and that at least 32 of 43 
representative unencapsulated isolates lost their capsule because of the inactivating mutations 
related to the two glycosyltransferase genes (cps2E and cps2F). The unencapsulation was 
further demonstrated to enhance bacterial adherence to both porcine and human platelets and 
increase the ability to form biofilm. In addition, the data from this study suggested possible 
advantage of the presence of unencapsulated subpopulations to the entire S. suis population. 
Although it is generally accepted that the loss of the capsule diminishes the virulence of the 
S. suis strain, loss of capsule production is demonstrated to be advantageous for S. suis to 
cause infective endocarditis and further analysis incorporating the findings of this study may 
provide novel insights into the pathogenic mechanisms of S. suis infections. However, 
because both encapsulated and unencapsulated cells have not confirmed to be retrieved from 
the same case, the additional experiments are necessarily required for verifying this 
hypothesis. 
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